University of Missouri, St. Louis

IRL @ UMSL
Dissertations

UMSL Graduate Works

7-27-2007

MECHANISM OF SPLICING REGULATION
BY THE MEIOSIS ENHANCER FACTOR
Mer1p IN YEAST Saccharomyces cerevisiae
Javier Armisen Garrido
University of Missouri-St. Louis, j_armisen@yahoo.es

Follow this and additional works at: https://irl.umsl.edu/dissertation
Part of the Biology Commons
Recommended Citation
Armisen Garrido, Javier, "MECHANISM OF SPLICING REGULATION BY THE MEIOSIS ENHANCER FACTOR Mer1p IN
YEAST Saccharomyces cerevisiae" (2007). Dissertations. 581.
https://irl.umsl.edu/dissertation/581

This Dissertation is brought to you for free and open access by the UMSL Graduate Works at IRL @ UMSL. It has been accepted for inclusion in
Dissertations by an authorized administrator of IRL @ UMSL. For more information, please contact marvinh@umsl.edu.

MECHANISM OF SPLICING REGULATION BY THE MEIOSIS ENHANCER
FACTOR Mer1p IN YEAST Saccharomyces cerevisiae
by
JAVIER ARMISEN GARRIDO
M.Sc., Biology, University of Missouri-St. Louis (USA), 2003
B.S., Biology, Universidad Autonoma de Madrid (SPAIN), 2002
B.S., Biochemistry, Universidad Autonoma de Madrid (SPAIN), 2001
A DISSERTATION
Submitted to the Graduate School of the UNIVERSITY OF MISSOURI-ST.LOUIS In
Partial Fulfillment of the Requirements for the Degree
DOCTOR OF PHILOSOPHY
in
BIOLOGY
with an emphasis in Cellular and Molecular Biology
St.Louis, May 2007

Dissertation Advisory Committee
Marc spingola, Ph.D.
Advisor/Chair
Shirley Bissen, Ph.D.
Michael R. Nichols, Ph.D.
Wendy Olivas, Ph.D.
Teresa Thiel, Ph.D.

ABSTRACT
In eukaryotes, genes are presented in a series of coding and non-coding DNA
regions (exons/introns) that are transcribed into a premature RNA (pre-mRNA). Introns
can be removed from the mature premRNA, before its translation into proteins, in a
process called splicing. The splicing reaction occurs in two highly regulated
transesterification reactions inside of the cell nucleus, and it is catalyzed by the
Spliceosome, involving the binding and release of five small nuclear ribonucleoprotein
particles (snRNPs). While some introns are constitutively spliced, others can be
alternatively spliced, giving different exon combinations and therefore different proteins,
increasing the protein diversity of the species. In humans, misregulation of alternative
splicing can result in the production of aberrant proteins, some of which may produce
cancer or other severe diseases.
In yeast, alternative splicing is regulated by different splicing factors, such as
Mer1p. Mer1p is expressed during meiosis in the yeast Saccharomyces cerevisiae and
activates the splicing in at least three different genes (AMA1, MER2, and MER3), which
contain a conserved intronic splicing enhancer sequence. Previous results have shown
that Mer1p is able to interact with the pre-mRNA and with specific proteins of the U1
and U2 snRNPs. However, the specific molecular mechanisms by which Mer1p activates
splicing remained unknown. The objective of this work is to determine how Mer1p
regulates the splicing of its targets, and how different splicing factors modulate Mer1p
activity.

II

Using biochemistry and genetics, the data presented in this work indicate that
Mer1p recruits the snRNPs U1, U2 and U6, to pre-mRNA. This recruitment of the
snRNPs is dependent of the U1 snRNP protein Nam8p and the U2 snRNP protein
Snu17p, but independent on the branchpoint region or ATP. Furthermore, Mer1p
accelerates and stabilizes the formation of the early complexes of the spliceosome.
Finally, U1 and U2 are recruited to the pre-mRNA at the same time, emerging a
new alternative hypothesis of splicing regulation that can be applied to other enhancer
regulators and that differs from the classical model of stepwise assembly of the snRNP.
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CHAPTER I

INTRODUCTION
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1.1 Pre-mRNA Splicing
The genomic information encoded in the genes is transcribed into an intermediary
RNA before it can be translated into proteins. The transcription reaction occurs inside of
the cell nucleus and is carried out by the RNA polymerase II (only for mRNAs), which
creates a primary transcript or precursor mRNA (pre-mRNA). The premRNA undergoes
a series of modifications before it can be exported to the cytoplasm as a mature RNA
(mRNA), where it can be translated into protein (Figure 1.1).
Approximately 90% of human genes and 4% of yeast genes contain non-coding
sequence or introns that interrupt the coding sequence or exons (Spingola, Grate et al.
1999), and which need to be removed from the primary transcript. The process of intron
removal and proper exon joining is called splicing, and it occurs inside of the cell
nucleus. The splicing process is a highly conserved mechanism among species, with
some particularity in each case. For example, all yeast introns contain highly conserved
sequence elements that provide the proper signals for the splicing reaction. These
sequences are the 5’splice site (5’ ss), the branchpoint sequence (bps), and the 3’ splice
site (3’ ss). Interestingly, these sequences are more conserved in lower eukaryotes (the
yeast Saccharomyces cerevisiae) than in higher eukaryotes. In yeast, the 5’ splice site is
almost always GUAYGU while in humans, only the first GU sequence is highly
conserved. The branchpoint sequence is usually UACUAAC in yeast and CAAUCAU in
metazoan (although it can be more degenerate), where the last adenosine is highly
conserved in both situations. Finally, the 3’ splice site is a short sequence YAG, which in
some organisms is preceded by a conserved pyrimidine track located between the

Armisen Garrido, Javier, UMSL, 2007 p.7
branchpoint sequence and the 3’ splice site. This pyrimidine track is not that apparent in
the yeast Saccharomyces cerevisiae.
In addition to these well characterized signals, introns and exons may contain
additional sequences that are also involved in the splicing process and can act as positive
or negative regulators. These sequences are named enhancer or silencer elements.
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Figure 1.1

Processing of the genomic information. After the transcription

reaction, the pre-mRNA needs to remove the intronic sequences to form the mature RNA
(mRNA) in a process called splicing. The splicing reaction occurs inside of the cell
nucleus before the mRNA can be exported to the cytoplasm and translated into proteins.
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1.2 Splicing Reaction
The splicing reaction occurs in two highly regulated ATP-independent
transesterifications reactions (Reed and Hurt 2002) (Figure 1.2). During the first
transesterification a 2’ hydroxyl group from the conserved adenosine residue located
within the branchpoint sequence (UACUAAC) carries out a nucleophilic attack over the
5’ splice site (GUAYGU). Consequently a free 3’ hydroxyl group on the 5’ exon and a
lariat-intron-3’ exon splicing intermediate are formed. In the second transesterification
reaction, the 3’ hydroxyl on the 5’ exon attacks the 3’ splice site (YAG), leading to the
ligation of the two exons and the release of the lariat-intron product (Staley and Guthrie
1998; Reed and Hurt 2002). In yeast, the two transesterifications reactions are catalyzed
by a 40S ribonucleoprotein complex described for the first time in 1985 by Brody and
Abelson as the spliceosome (Brody and Abelson 1985). In humans, purification and
electron microscopic visualization of the functional spliceosome identified a larger
particle (60S). The difference in size between the yeast and the human spliceosome are
due to a more complex spliceosome organization in humans, and the presence of
additional factors such as the Serine/Arginine-residue proteins (SR family of proteins,
Fabrizio, Esser et al. 1994; Zhou, Licklider et al. 2002). Since the splicing signals are less
conserved in higher eukaryotes, SR proteins are required to assist in the identification of
the proper splicing signals of a given transcript. Indeed, SR proteins can interact with the
U1 particle during the early steps of spliceosome assembly, putting in close proximity
essential sequences of the pre-mRNA required for the proper splicing efficiency of some
human genes (Kent and MacMillan 2002).
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Figure 1.2

Overview of the splicing reaction. The splicing reaction takes place

in two ATP-independent transeterifications. At the end of the second transesterification,
exons are joined leaving a lariat-intron product that will be degraded.
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1.3 Splicing Machinery
1.3.1 Spliceosome
Other than the difference in size between the human and yeast spliceosome, the
basic structure and organization is conserved. In both cases, the spliceosome is formed of
five small nuclear ribonucleoprotein particles or snRNPs (U1, U2, U4, U5 and U6), and
each snRNPs is composed of a small nuclear RNA (U1, U2, U4, U5 and U6) and a
number of proteins, some of which are shared among the snRNPs. For example, while
U1, U2, U4 and U5 snRNAs bind to a common core of Sm proteins (B, D1, D2, D3, F
and G) (Branlant, Krol et al. 1982; Zhang, Abovich et al. 2001), U6 snRNA binds to likeSm (Lsm) protein core, composed of seven proteins (Lsm2 to Lsm8) (Beggs 2005;
Mayes, Verdone et al. 1999). In addition, each snRNA binds to a specific group of
proteins, many of them named Prp (Pre-mRNA Processing proteins). Moreover, there are
over 75 non-snRNP proteins associated with the spliceosome that are also required for
the formation of the spliceosome. Some of theses proteins are members of DExD/H-box
RNA helicases, which are required for the formation of the active spliceosome, and might
interact directly with the splicing machinery (Tanner and Linder 2001; Cordin,
Banroques et al. 2006). Finally, there is a group of non-snRNP factors that bind directly
to the pre-mRNA and influence the activity of the spliceosome. Among these factors are
the yeast proteins Mud2p and Bbp1p, which recognize and bind to the branchpoint
region, or the cap binding proteins Cbp20p and Cbp80p, which bind to the 5’ exon and
modulate the binding of U1 snRNP. (Spliceosomal proteins are reviewed in Jurica and
Moore 2003)
The splicing reaction involves the binding and release of the five snRNPs and
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protein factors (Figure 1.3). It also involves the formation and disruption of RNA helices,
RNA-RNA, RNA-protein and protein-protein interactions, between snRNPs and between
snRNPs and the pre-mRNA. Most of these rearrangements are ATP-dependent, but in
some cases the reaction requires the hydrolysis of GTP (Nilsen 1994; Nilsen 2003).
The current model for spliceosome formation in vivo includes an ordered stepwise
assembly of the snRNPs that occurs co-transcriptionally (Figure1.3) (Lacadie and
Rosbash 2005; Lacadie, Tardiff et al. 2006; Tardiff and Rosbash 2006) that is initiated by
the binding of U1 snRNP to the pre-mRNA shortly after the RNA polymerase transcribes
the 5’ splice site. This binding is mediated by base pairing interactions between the 5’
end of U1 snRNA with the conserved sequences at the 5’ splice site. This association
forms the commitment complex I in yeast, or early (E) complex in mammals.
Subsequently, the branchpoint sequence is recognized by the branchpoint binding protein
Bbp1p/SF1 in a sequence-specific reaction, forming commitment complex II or A
complex in metazoans. Then the U2 snRNP binds to the complex to form the yeast prespliceosome or B complex in mammals. The binding of U2 snRNP to the pre-mRNA
involves the recognition of the branchpoint sequence by base pairing with U2 snRNA
(Seraphin and Rosbash 1991). Finally, the tri-snRNP complex of U5 and the base paired
U4-U6 snRNPs stably joins the pre-spliceosome.
After the binding of the tri-snRNP, the U4-U6 snRNA duplexes unwind, and the
U4 and U1 snRNPs are released from the spliceosome complex (Figure 1.3). Now U6
snRNA can form base pair interactions with the 5’ splice site and with a region of U2
snRNA located close to the binding between U2 and the branchpoint sequence (Patel and
Steitz 2003). Once all these RNA rearrangements occur, the spliceosome is completely
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active to execute the first transesterification reaction that leads to the cleavage of the 5’
exon from the intron and produces the lariat-intron-3’ exon intermediate. After the first
transesterification reaction, a new rearrangement of the catalytically active spliceosome
must follow in order to allow the second transesterification reaction, which leads to
splicing of the exons and excision of the intron. (Staley and Guthrie 1998; Hastings and
Krainer 2001). In S. cerevisiae, after the exon junction, the lariat intron is debranched by
Dbr1p protein and is finally degraded (Chapman and Boeke 1991).
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Figure 1.3

Spliceosome assembly and recycling pathway. Evidence from in

vitro and in vivo studies supports a stepwise model where all the spliceosome elements
are assembled to the pre-mRNA sequentially manner (Weaver 2002).
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1.3.2 Spliceosome Assembly
Even though recent evidence supports the stepwise assembly model in vivo
(Tardiff and Rosbash 2006), results from experiments from in vitro studies have
suggested that the spliceosome could be working as a holoenzyme, a pre-assembled
complex. The “Holospliceosome” or Penta-snRNP model was first described by the
Abelson’s group in 2002 when they were able to isolate, under low salt conditions, a
functional complex containing all the snRNPs (Stevens, Ryan et al. 2002) and additional
factors associated specifically with the penta-snRNP, including eight proteins of the
Prp19-complex (which are specific components of the active spliceosome) (Chen, Yu et
al. 2002; Chan, Kao et al. 2003; Chen, Kao et al. 2006). Additional support for this model
came from the finding that U2 snRNP was able to associate with the tri-snRNP without a
pre-mRNA (Konarska and Sharp 1988), and that the U1 snRNA was able to form base
pairs with the 5’ splice sites in a penta-snRNP context (Malca, Shomron et al. 2003).
Evidence against the penta-snRNP formation comes from the finding that in vitro, the
formation of the functional spliceosomal A complex is possible, even in the absence of
the tri-snRNP (blocking the possibility of a penta-snRNP formation) (Behzadnia,
Hartmuth et al. 2006).
In both models, there is a consensus that during the spliceosome assembly RNARNA, RNA-protein and protein-protein interactions play a key role in the dynamic
progression of the reaction, and that during the splicing reaction one interaction is
required to be disrupted in order to progress to form another.

Armisen Garrido, Javier, UMSL, 2007 p.16
1.3.2.1 Commitment Complex Formation
Spliceosome formation is initiated with the 5’ splice site recognition by U1
snRNP, forming the commitment complex I (CCI). It is designated commitment complex
because once the U1 snRNP is bound to the pre-mRNA, it commits the pre-mRNA to the
splicing pathway. CCI is stabilized by the base pair interaction between the 5’ end of the
U1 snRNA and the conserved 5’ splice site sequence (Rosbash and Seraphin 1991). In
yeast, U1-C protein interacts with the 5’ splice site before its base pairing with the U1
(Du and Rosbash 2002). Additionally, crosslinking experiments have shown direct
interactions between several U1 snRNP proteins (U1-70K, Snu56p, Prp40, Nam8p,
Prp39p, U1-C, and Sm core proteins) and the pre-mRNA at the 5’ splice site region
during the formation of CCI, and therefore the stabilization of the U1 snRNP with the
pre-mRNA requires proteins-RNA interactions and RNA-RNA interactions (Gottschalk,
Tang et al. 1998; Zhang and Rosbash 1999; Jurica and Moore 2003).
Interestingly, some components of U1 snRNPs have additional roles besides their
splicing regulation. For example, the U1 snRNP protein Prp40p has been associated with
the nuclear export machinery, indicating that spliceosome components can act at different
stages during the cell cycle and in different cellular events (Murphy, Olson et al. 2004).
Additional factors involved during the formation of the CCI include the yeast Cap
Binding Complex (yCBC), which increases the efficiency and stability of the U1 binding
to the pre-mRNA (Lewis, Gorlich et al. 1996; Lewis, Izaurralde et al. 1996). Its function
was determined by a genetic screen to find components that showed synthetic lethality
with the yCBC cbp20-∆ and cbp80-∆ double mutations. During the screening, a group of
U1 snRNPs components was found to be synthetic lethal with the yCBP deletions.
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Finally, this result, together with the characterization of physical interactions between the
yCBC components of the commitment complex (Snu56p as part of U1 snRNP) and other
splicing factors (Mud2p), suggested that yCBC could be not only directly regulating the
spliceosome formation, but could also be regulating the later steps of the spliceosome
assembly (Fortes, Kufel et al. 1999).
After the formation of CCI, Bbp1p recognizes and binds to the highly conserved
branchpoint sequence. This interaction is mediated through the KH-domain at the Nterminal region of Bbp1p, and together with Mud2p assists in the recruitment of U2
snRNP to the branchpoint sequence (Figure 1.4) (Berglund, Fleming et al. 1998; PeledZehavi, Berglund et al. 2001). In addition, Mud2p interacts directly and simultaneously
with the pre-mRNA and the U2 snRNP protein Prp11p. Surprisingly, even though Mu2dp
does not bind directly to the bps (binds to the 3’ region of the bps) it requires the
branchpoint sequence and Bbp1p in order to bind to the pre-mRNA (Rutz and Seraphin
1999). Finally, Mud2p also increases the binding affinity of Bbp1p to branchpoint
sequence, suggesting cooperative binding among the different elements of the splicing
machinery (Abovich, Liao et al. 1994; Berglund, Abovich et al. 1998). The association of
Bbp1p and Mud2p to the pre-mRNA forms commitment complex II (CCII) or A complex
in metazoans (metazoans require additional factors, such as U2AF35, to form the A
complex) (Abovich and Rosbash 1997; Fortes, Kufel et al. 1999).

1.3.2.2 The Pre-Spliceosome
After the binding of Bbp1p and Mud2p, the U2 snRNP is recruited to the
branchpoint region forming the pre-spliceosome complex. Interestingly, in vivo the
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recognition of the branch site region by the U2 snRNP does not involve the base pairing
of U2 snRNA and the pre-mRNA (Rain and Legrain 1997). Indeed, U2 snRNP is first
associated with the branch site region in an ATP-dependent manner, and then U2 snRNA
base pairs with the branchpoint sequence, displacing Bbp1p from the pre-mRNA. The
process of disruption and formation of new base pairs during the pre-spliceosome
formation is regulated by the ATPases, Sub2p and Prp5p. Sub2p is an essential DECD
box putative ATPase involved in the transition from CCII to pre-spliceosome and
requires Mud2p for its function (Kistler and Guthrie 2001; Libri, Graziani et al. 2001).
Sub2p is also involved in mRNA export, constituting another example in which the
splicing reaction works as a part of complex nuclear network of events and not as an
isolated event (Jensen, Boulay et al. 2001; Zhang and Green 2001).
Before the splicing reaction can progress to the formation of the pre-spliceosome,
the U2 snRNP particles SF3a and SF3b need to bind to the upstream region of the
branchpoint sequence. Moreover, both factors are required for the proper conformation of
the U2 snRNA binding to the branchpoint sequence, and the stable formation of the prespliceosome complex (Wiest, O'Day et al. 1996). In addition, the stable addition of U2
snRNP to the pre-mRNA is ATP-dependent and requires the DEXD/H box ATPase
Prp5p (Xu, Newnham et al. 2004), although the pre-spliceosome formation can also
occur in the absence of ATP, but only when the U2-associated splicing factor Cus2p
protein is missing or when the downstream conserved region of U2 snRNA has been
removed (Perriman and Ares 2000; Perriman, Barta et al. 2003).
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Figure 1.4

Assembly of the commitment complex and pre-spliceosome. Once

U1 snRNP binds to the pre-mRNA, the pre-mRNA is committed to splice. snRNP
proteins as well as snRNAs and non-snRNP proteins are required for the proper
recognition, binding and stabilization of the different complexes during the spliceosome
assembly.
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1.3.2.3 Tri-snRNP Addition and RNA Rearrangements
Following the U2 snRNP binding, U4/U6-U5 tri-snRNP binds to the prespliceosome, forming new interactions, while rearranging others (Figure 1.4). For
example, the U5 snRNA interacts in an ATP-dependent reaction with the 5’ splice site
region while U1 is still bound there. These new base pairs are located in a different 5’
splice site region than the base pairs between the U1 snRNA and the pre-mRNA, and
they allow interactions between U1 and U5 snRNPs (Newman, Teigelkamp et al. 1995;
Fromont-Racine, Rain et al. 1997). Also new base pairs between the 5’ end of U2 snRNA
and the 3’ end of U6 snRNA are formed. At the same time, the 5’ splice site region of U6
RNA, which formed base pairs with the U4 snRNA, then forms new base pairs with the
U2 snRNA. The U6 snRNA also forms RNA-RNA interactions with itself. The
unwinding process of U4 from U6 is mediated by the DExD/H-box ATPase RNAhelicase Brr2p (Kim and Rossi 1999; Raghunathan and Guthrie 1998), and it is an
important requirement for the progression of the spliceosome.
After the addition of the tri-snRNP and the cross-intron interactions have
occurred, U1 and U4 snRNPs are displaced, allowing the binding of U6 snRNA with the
5’ splice site. This process of separating the base pairs between U1 snRNA and the 5’
splice site requires the activity of the ATPase helicase Prp28p (Staley and Guthrie 1999).
In the active spliceosome, U6 snRNA base pairs with U2 snRNA (bound at the same time
to the bps) at the same time that it base pairs with the 5’ splice site, (Kim and Abelson
1996).
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In addition to the helicases, there are other splicing factors involved in the
rearrangement of the active spliceosome, such as the Prp19-associated complex and the
DExD/H-box protein Prp2p, which function in the unwinding of U4 and U6.
Finally, during the last step of the splicing reaction, the release and recycling of
the snRNPs require more RNA-RNA rearrangements. U6 needs to leave the 5’ splice site,
U2, the branchpoint sequence, and U5, the exons (Staley and Guthrie 1998).
All of these rearrangements that occur along the splicing reaction are driven by
several splicing factors that have been classified into 3 different groups. Group I contains
factors with a RNA recognition motif; Group II factors are the ATPases DEx/H box
proteins; and Group III factors are the GTPases (Staley and Guthrie 1998). Group I
includes Mud2p/U2AF65 because of their ability to assist in the base pairing of U2 with
the branchpoint sequence through its RRM motifs (Abovich, Liao et al. 1994; Valcarcel,
Gaur et al. 1996). The Group II factors are composed of ATPases DEx/H box proteins
(Brr2p), which are believed to unwind the RNA helix of snRNAs and RNA-RNA
interactions between snRNAs (reviewed in Tanner and Linder ; Tanner and Linder 2001).

1.3.3 The Catalytic Core
Once all the rearrangements are completed, the active spliceosome catalyzes the
first transesterification reaction, which is believed to be catalyzed by the snRNAs and not
the proteins of the snRNPs (Nilsen 2000; Valadkhan and Manley 2001). After the first
transesterification reaction, significant conformational changes must occur before the
second catalytic reaction takes place, including the displacement of the branch lariat and
the alignment of both exons (Figure 1.5). The second catalytic step requires the three
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consensus intron sequences (the 3’ splice site (YAG) being the most critical region). The
splicing signals interact among themselves to facilitate the 3’ splice site identification,
and in this way they enhance the fidelity of splicing and ensure the coupling between the
first and second transesterification (Umen and Guthrie 1995). Interestingly, mutation in
the first G of the 5’ splice site affects the efficiency of the second step. The explanation
for this effect is the consequence of disruption in the interaction between the first G of the
5’ splice site and the last G of the 3’ splice site (Parker and Siliciano 1993; Chanfreau,
Legrain et al. 1994). Additionally, the U6 snRNA, and to a lesser extent the U2 snRNA,
are required for the second transesterification reaction. Moreover, the U5 snRNA plays
an important role in this second step because it is responsible for the proper alignment
between exons (Newman 1997). After the first catalytic reaction, the conformation of U5
snRNA changes in such a manner that its conserved U rich loop (located at the end of a
stem structure) is in close proximity to the reactive groups of the 5’ exon and 3’ exon
(Figure 1.5). This U5 loop has the ability to interact with the reactive groups in a nonspecific sequential manner, and therefore it brings together both exons.
Additionally, there is a set of specific proteins required for the second catalytic
step. Some of them belong to the superfamily of DEXH ATPases (such as Prp16p), while
others are ATP-independent proteins required for the proper 3’ splice site selection
(Slu7p), or snRNP stability (Prp8p) during the second transesterification (reviewed in
Umen and Guthrie 1995).
At the end of the second transesterification, the mature mRNA is released, leaving
the lariat intron and a complex that contains the U2, U5 and U6 snRNPs. Then the U2,
U5 and U6 snRNPs complex dissociates. The snRNPs are recycled for future splicing
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reactions and the lariat intron is degraded by exonucleases with the help of the
debranching enzyme Dbr1p (Chapman and Boeke 1991; Khalid, Damha et al. 2005).
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Figure 1.5

RNA rearrangement during the splicing reaction. Representation of

RNA-RNA interactions prior to the first transesterification reaction (top), and the second
transesterification reaction (bottom). The transition from the first transesterification
reaction to the second requires several RNA-RNA rearrangements including the
formation of new base pairs between the U5 snRNA and exon 2 (required for the proper
alignment between exons) (Umen and Guthrie 1995).
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1.4 Alternative Splicing
The process by which some exons/introns of some pre-mRNAs are included while
others are excluded from the mRNA is denoted alternative splicing (Figure 1.6). In
humans, between 40-74% of the genes undergo an alternative splicing process and up to
80% of alternative spliced genes experience changes in the final protein (Modrek and Lee
2002). This number increases if additional results from different studies of alternative
splicing, such as microarrays, are taken into account. The importance of alternative
splicing is that up to 50% of human genetic diseases are related to mutations in elements
that regulate accurate splicing (Faustino and Cooper 2003). For example, cystic fibrosis
has been linked with mutations in cis-acting elements and trans-acting factors that lead to
aberrant splicing of pre-mRNA and, therefore, an abnormal protein production. As occurs
in metazoan, some yeast exons are constitutively spliced while others can be alternatively
spliced, producing different exon/intron combinations and, therefore, different proteins
form. In all the species, the result of alternative splicing is an increase in the proteomic
diversity, which is considered one of the major contributors to protein diversity in
metazoan organisms. In some, alternative splicing working as an evolutionary tool can
provide the organisms with new advantages (Graveley 2001).
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Figure 1.6

Variants of alternative splicing. (A) An exon can be included or

excluded from the final mRNA. (B, C) The alternative use of 3’ or 5’ splice site can
affect the length of the final mRNA. (D) In some cases, the inclusion of a cassette exon
can cause the exclusion of the next one. (E) If an intron is retained, the mature transcript
can be exported and translated, giving a new protein isoform. The combination of some
or all of these effects can take place in the same pre-mRNA during the splicing process
(Black 2003).
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Alternative splicing includes conserved and species-specific mechanisms of
action, and its regulation involves the participation of positive (enhancer) and negative
(repressor) cis and trans-acting elements (Thanaraj, Clark et al. 2003). These enhancer or
repressor elements can assist in the selection of the 5’ splice site, as well as the 3’ splice
site (Black D., 2003), therefore selecting for the inclusion or exclusion of a given
intron/exon.
Interestingly, although the spliceosome machinery is well studied, the molecular
details of how regulators alter splice site recognition remains largely unknown. The
effects of alternative splicing are important in many cellular and developmental
processes, including sex determination, apoptosis, axon guidance, cell excitation and
contraction, and many others (Faustino and Cooper 2003). Changes in splice site choice
result in changes in the assembly of the spliceosome. As occurs in metazoans, the
selection of specific splice sites in yeast can be regulated by altering the binding site of
the initial factors to the pre-mRNA and the formation of early spliceosome complexes.
Once the CCI is formed, the bound intron or exon is committed to be spliced (Black
2003; Graveley 2001).
During the process of alternative splicing, the 5’ and 3’ consensus sequences are
generally not sufficient for the assembling of the spliceosome and additional information
and interactions are required to activate the use of a specific site. In this sense many non–
splice site regulatory sequences can modulate the spliceosome assembly. These auxiliary
sequences are highly variable and can act positively to stimulate spliceosome assembly
(splicing enhancer sequences), or negatively, acting as splicing silencers or repressors
that block the spliceosome assembly. Moreover, these cis-elements can be located in the
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exon (exonic splicing elements) or in the intron (intronic splicing elements). The intronic
splicing elements are often found within the polypyrimidine tract or immediately adjacent
to the branchpoint or 5’ splice site, and in some cases they can act from a distance.
Finally, there are several different splicing factors that can work in trans to
regulate the splice site selection (Black 2003). As an example of trans-acting factors,
there are the exonic splicing regulatory proteins of the SR-family (Blencowe 2000). SR
proteins are essential regulatory factors, with a common C-terminal domain (structure of
one or more arginine(R)/serine(S) dipeptides), and a N-terminal RNA recognition motif
that binds to RNA. Other splicing factors involved in the splicing reaction also contain
RS domains but serve in different roles than the SR proteins. Such factors are the
mammalian U2 auxiliary factor U2AF, which recognizes the branchpoint sequence and
the U1 snRNP protein U1-70K (Graveley 2000; Zhang, Abovich et al. 2001).

1.4.1 Mechanism of Alternative Splicing Regulation
The majority of the information obtained regarding splicing activators comes
from studies in SR proteins. SR proteins can bind to exons containing enhancer sequence
elements (ESE), and activate specific 5’ or 3’ splice sites (Tacke and Manley 1999), such
in the case of the Drosophila sex-specific gene DSX, where the ESE element is formed by
a purine-rich sequence. In this case, the SR proteins in combination with additional
female-specific regulators (TRA and TRA2) assist in the recruitment of the splicing factor
U2AF65 to a weak polypyrimidine track located near the 3’ splice site. In addition,
biochemical experiments have shown interactions between the RS domains of the SR
proteins with the U1-70K protein, suggesting a way to activate a specific 5’ splice site
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(Du and Rosbash 2002). This result also indicates that splicing regulatory elements could
modulate the spliceosome assembly by direct interactions with their components.
Additional ways to stimulate the use of alternative splice sites can come through
intronic splicing enhancers (ISEs). This is the case of TIA1, an apoptosis-promoting
factor and homologue of the yeast U1 protein Nam8p, TIA1p binds to a uracil-rich ISE
and promotes the recruitment of U1 snRNP to weak 5’ splice sites by interacting directly
with the specific U1-C protein (Figure 1.7) (Forch, Puig et al. 2000; Forch, Puig et al.
2002).
In some cases, alternative splicing regulation involves silencer elements. For
example, SR proteins have the ability to recognize and bind to an intronic sequence near
the 3’ splice site of the L1 pre-mRNA. Once the SR proteins bind to this region, the 3’
splice site is no longer available for the splicing machinery and a new 3’ splice site must
be selected.
Both negative and positive regulation can act at the same time in the same premRNA and it is the balance between enhancers/activators and silencers/repressors that
determines many of the alternative splicing events.
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Figure 1.7

TIA1p splicing regulation. TIA1p recognizes and binds to U-rich

sequences located in the intron near the 5’ splice site. Once TIA1p is bound, it promotes
the assembly of the spliceosome machinery to its proximal 5’ splice site by interacting
directly with the U1 snRNP.
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1.4.2 Misregulation of Alternative Splicing in Human Diseases
Current studies using global approaches, such as in vitro binding and in vitro
functional experiments or in vivo functional selection, have been used to identify general
regulatory sequences of alternative splicing. These techniques, in combination with
computational approaches, have been used to search for more specific motifs involved in
the regulation of alternative splicing. One successful approach that has provided valuable
information about alternative splicing regulation started with a particular splicing
regulator and defined which pre-mRNAs were regulated under its expression, as well as
at which step of the splicing reaction it was involved. The information collected from the
different approaches has linked misregulation of the alternative splicing reaction with
several human genetic diseases such as cystic fibrosis or myotonic dystrophy (see Table
1.1 for details, Matlin, Clark et al. 2005).
Interestingly, about 10% of the mutations that occur in the human genome affect
the splicing sites, leading to abnormal exon/intron definition and resulting in an
inappropriate inclusion or exclusion of a given exon/intron. In some cases, mutations can
cause a gain or loss of splicing function depending on where and when during the cell
cycle they occur. Mutations could create cryptic splicing sites, ESEs, ESSs, ISEs, ISSs
and lead to the activation of specifics splice sites, therefore, contributing to the splicing of
the wrong exon/intron producing the erroneous mRNA. Even single-nucleotide mutations
can activate or weaker splice sites. Mutations that inactivate cis-acting splicing elements,
such as the canonical splice sites, can lead to a loss of splicing function (such in the
splicing for β-globin). Mutations can also affect trans-acting splicing regulators involved
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in the regulation of splicing, such in the case of myotonic dystrophy (Faustino and
Cooper 2003).
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Disease
Familial isolated growth
hormone deficiency type II
Frasier syndrome

Alteration

Cause

Symptons

Disruption in alternative splice site

Mutation in the GH gene producing
Short stature
miss balance in the isoform ratio

Disruption in alternative splice site

Change in the +KTS/-KTS ratio

Frontotemporal dementia and
Parkinsonism linked to
Disruption in alternative splice site
Chromosome 17

Urogenital disorders involving kidney and gonad
developmental defects

Mutations in the MAPT gene; alteration Aggregation of the microtubule-associated protein
in the ratio of tau isoforms
tau in neurons; Alzheimer
Loss of function of the cystic fibrosis
Severe pulmonary and pancreatic disease; Male
transmembrane regulator (CFTR) gene
infertility
caused by exon 9 skipping
Alteration in genes involved in the
Progressive retinal degeneration.
function of the U4/U6·U5 tri-snRNP
Disruption of an ESE in exon 7 causing
Progressive loss of spinal cord motor neurons;
the exon to be skipped in SMN2
paralysis of muscles.
mRNAs
Increase number CTG triplet repeat.
Skeletal muscle hyperexcitability; cardiac
Overexpression of splicing regulator,
conduction defects; cataracts; muscle dysfunction;
resulting in misregulated splicing of its testicular atrophy; neuropsychiatric and cognitive
target pre-mRNAs
disturbances

Atypical cystic fibrosis

Disruption in alternative splice site

Retinitis pigmentosa

Basal splicing machinery

Spinal muscular atrophy

Basal splicing machinery

Myotonic dystrophy

Regulator of alternative splicing

Neoplasia and Malignancy

Regulator of alternative splicing

Trans-acting regulatory factors

Anaplasia, invasion, and metastasis

Activation alternative splice site

Activation of a criptic 3' ss in the
globin gene

Severe severe anemia and sometimes death

Table 1.1

Misregulation of splicing in human diseases (Cooper and Mattox 1997; Faustino and Cooper 2003).
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Furthermore, some mutations can exhibit high phenotypic variability depending
on cell type and individuals, and in some situations (Cystic Fibrosis) the phenotypic
diversity is a combined effect of cis-acting splicing elements and trans-acting factors
(Nissim-Rafinia and Kerem 2002). Because alternative splicing can produce several
protein isoforms at the same time, it is the umbalanced ratio of these different isoforms
that can cause improper cellular function. For example, the human disease Alzheimer’s is
caused, in part, by a variation in the ratio of the different tau proteins isoforms, caused by
a mutation in a cis-acting splicing element (Hong, Zhukareva et al. 1998).
Can gene therapy prevent genetic diseases associated with alternative splicing?
There are several treatments focusing on blocking the effects of misregulation in
alternative splicing, including drugs designed against specific isoforms of the protein
based on their unique sequence, or alterations in the gene expression of specific mRNAs,
so that the correct isoform of the protein is predominant over a pool of isoforms. In cases
where the gene is regulated by a specific splicing factor, it is possible to affect the
function of such a factor and in this way to block its effects. Finally, the use of
oligonucleotide-based compounds as an alternative treatment has been tested.
Oligonucleotide-based compounds have the ability to bind specifically to cis-acting
regions in the pre-mRNA and inhibit or activate specific splicing sites by blocking or
recruiting splicing elements. In all these cases, the creation of a specific treatment against
a splicing defect requires first a deep understanding of how the splicing reaction works
and how it is regulated at different stages in different cells.
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1.5 Splicing during Meiosis
During starvation periods the budding yeast Saccharomyces cerevisiae goes
through the meiosis process, inducing the expression of over 100 genes (Burns,
Grimwade et al. 1994). These genes, which can be expressed at very low levels during
vegetative growth, have been identified based on their ability to produce specific meiosis
defects when they are mutated, or increase their expression when the cell enters into
meiosis. The activation of sporulation genes occurs at distinct times during the
developmental process. The timing of their expression has been categorized as early,
middle, and late genes, depending on when their transcription take place during
sporulation (Table 1.2). Briefly, early genes are expressed at the initial stage of meiosis
(beginning of Prophase I) and are usually involved in DNA synthesis and DNA
recombination. This group of genes is the best studied. Middle and late genes are more
difficult to classify due to their unique time of expression and strain-specificity. Middle
genes would be those ones expressed during later prophase I, while late genes would be
expressed at the end of cell division and sporulation. Most of the sporulation genes are
regulated at the transcription level during the early process of meiosis, and the products
of IME1 and IME2 are believed to be responsible for the induction of the transcription of
these genes (reviewed in Mitchell 1994). In some cases, some meiotic genes are
modulated post-transcriptionally, like MER2, which is regulated by the enhancer
regulator Mer1p. Mer1p acts at the posttranscriptional level, and its gene product is
required for efficient splicing of AMA1, MER2 and MER3 transcript.
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Time of Expression
Early

Gene
DMC1
HOP1
IME1
IME2, SME1
IME4
MEI4
MEK1, MRE4
MER1
REC102
REC104
REC114
RED1
RIM4
SPO11
SPO13
SPO16
ZIP1

Function
Recombination
Recombination
Transcription
Transcription
Transcription
Recombination
Recombination
Splicing
Recombination
Recombination
Recombination
Recombination
IME2 expression
Recombination
Meiosis I division
Sporulation efficiency
Synaptonemal complex
formation

Middle

SIT2
SIT3
SIT4
SPO12
SPS1
SPS2
SPS3
SPS4

Central core RNA polymerase II
Unknown
G1/S transition
Meiosis I division
Post-meiotic events
Spore wall formation
Unknown
Unknown

Mid-late

DIT1
DIT2

Spore wall formation
Spore wall formation

Late

SGA1
SPR1
SPR2
SPR3
SPS100
SPS101

Glucoamylase; starvation
B-Glucanase
Unknown
Bud neck microfilament
Spore wall maturation
Unknown

Table 1.2

Sporulation gene expression (Mitchell 1994).
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1.5.1 Mer1p
Mer1p is a 31 kDa splicing factor expressed during prophase I of meiosis, and it is
not required for cell viability (Engebrecht, Voelkel-Meiman et al. 1991). MER1 mutants
are defective in meiosis recombination, producing inviable spores. Mer1p activates
splicing of introns containing a conserved intronic splicing enhancer sequence located
between the 5’ splice site and the branchpoint sequence (approximately 25 nt from the 5’
splice site). This enhancer element (AYACCCUY) has been found in at least three
different genes: AMA1, MER2 and MER3 (Davis, Grate et al. 2000; Engebrecht, VoelkelMeiman et al. 1991; Nakagawa and Ogawa 1999), some of which contain a weak 5’
splice site (MER3), a large 5’ exon (MER2) or a silencer sequence (AMA1). Mutations in
the enhancer element block the ability of Mer1p to activate splicing of MER3, MER2 and
AMA1 indicating that the enhancer is necessary for Mer1p-regulated splicing (Spingola
and Ares 2000).
It has been observed that at least one of the U1 snRNP proteins (Nam8p) is
required for Mer1p to activate splicing, and that Mer1p co-immunoprecipitates with U1
snRNA, indicating a physical interaction between Mer1p and the spliceosome machinery
(Spingola and Ares 2000). Although Nam8p is a U1 snRNP protein, its deletion does not
block the binding of Mer1p with the U1 snRNA, suggesting that the requirement of
Nam8p for Mer1p function could be independent of Mer1p-U1 snRNP interaction
(Spingola and Ares 2000).
The U1 snRNP protein Nam8p is an RNA binding protein essential for meiosis
but not for vegetative growth, and it is required for proper splicing efficiency of MER2,
MER3 and AMA1 pre-mRNAs (Nakagawa and Ogawa 1997; Nakagawa and Ogawa
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1999). Nam8p crosslinks near the 5’ splice site (Zhang and Rosbash 1999), and helps to
stabilize CCI on uncapped pre-mRNA or pre-mRNA with a weak 5’ splice site (Puig,
Gottschalk et al. 1999). Nam8p deletion also affects the structure of U1 snRNP, but does
not affect the formation of CCI. When Nam8p is deleted, the stability of two essential U1
snRNP proteins, Snu71p and Snu56p, are affected within the U1 snRNP complex
(Gottschalk, Tang et al. 1998). Therefore, Nam8p stabilizes the association of Snu71p
and Snu56p with the U1 snRNP.Moreover, Mer1p has an evolutionary conserved KHdomain (homology to hnRNP-K protein) that is a RNA-binding motif located at the Cterminal region, and it is involved in the recognition of the enhancer sequence (Figure
1.8).

Figure 1.8

Predicted Mer1p KH-domain by Swiss-model (Schwede, Kopp et

al. 2003). The left external loop followed by the small α-helix is predicted to be the
RNA-binding regions.
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The KH-domain can be replaced by an alternative RNA-binding motif, and still
the N-terminal of Mer1p is able to activate splicing (Spingola, Armisen et al. 2004). This
result, together with the fact that only the N-terminal region of Mer1p interacts with U1
snRNA, suggest that while the N-terminal domain is required for binding with the U1
snRNP, the C-terminal of Mer1p is required for the binding with the enhancer element.
Therefore, both domains contain independent functions.
In addition to activate the splicing of pre-mRNA with a long 5’ exon or a weak 5’
splicing site, Mer1p can also activate splicing of introns with mutations in the
branchpoint sequence (Spingola, Armisen et al. 2004). This suggests that Mer1p could be
acting at several steps during the spliceosome assembly, not only helping in the
formation/stabilization of CCI. Supporting the hypothesis that Mer1p acts at several steps
during the splicing pathway, two-hybrid interactions between Mer1p and different
proteins of U1 snRNP, U2 snRNP, and non-snRNP proteins were performed (Table 1.3).
Surprisingly, while Mer1p was not able to interact with Nam8p (despite its requirement
for Mer1p activity), Mer1p was able to interact with two Nam8p-associated proteins of
the U1 snRNP, Snu56p and Snu71p. Also, the two-hybrid experiment indicated a weaker
interaction between Mer1p and Bbp1p or Mud2p, two accessory splicing factors involved
in the recognition of the branchpoint sequence before the formation of CCII, and between
Mer1p and proteins of the U2 snRNP such Prp9p. These results support a model where
Mer1p accelerates or stabilizes the formation of commitment complexes and prespliceosome.
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Mer1p interactions
Protein Name

Function

Rho2p

Non-essential small GTPase. Establishment of cell polarity and in microtubule assembly

Uhs1p

Cytoplasmic serine/threonine protein kinase; Role in G1/S phase progression
Early stages of meiotic recombination; Alteration chromatin structure at DNA double-stranded break sites and in coordination

Rec107p
Srb4p

between the initiation of recombination and the first division of meiosis
Subunit of the RNA polymerase II mediator complex; Essential for transcriptional regulation

Mrp8p

Mitochondrial ribosomal protein

Snu56p/Mud10p Component of U1 snRNP; interacts with mRNA in commitment complex
Snu71p

Component of U1 snRNP

Prp11p

Subunit of the SF3a splicing factor complex, required for spliceosome assembly

Luc7p

Essential protein associated with the U1 snRNP complex; splicing factor involved in recognition of 5' splice site
Protein involved in early pre-mRNA splicing; component of the commitment complex; interacts with BBP splicing factor and

Mud2p
Msl5p
Prp9p
Rad52p
Spo13p

Sub2p
Component of the commitment complex; essential protein that interacts with Mud2p and Prp40p, forming a bridge between the
intron ends; also involved in nuclear retention of pre-mRNA
Subunit of the SF3a splicing factor complex, required for spliceosome assembly; acts after the formation of the U1 snRNP-premRNA complex
Protein that stimulates strand exchange; involved in the repair of double-strand breaks in DNA during vegetative growth and meiosis
Meiosis-specific protein, involved in maintaining sister chromatid cohesion during meiosis I as well as promoting proper attachment
of kinetochores to the spindle during meiosis I and meiosis II

Table1.3

Mer1p interactions. Mer1p interacts with many proteins involved in several cellular processes (SGD)
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1.6 Dissertation Overview
While the role of the splicing regulator Mer1p during meiosis has been previously
determined, its molecular mechanisms of splicing activation remain largely unknown.
Genetic interactions as well as biochemical experiments have shown that Mer1p interacts
with the snRNPs and that the non-essential U1 snRNP protein Nam8p is required for
Mer1p function. Although these results support a model where Mer1p could stabilize the
formation of commitment complex by interacting with the U1 snRNPs, they do not
demonstrate that Mer1p facilitates the binding of U1 snRNP or other snRNPs to premRNA to form commitment complexes or any other complex. Moreover, they might be
that more splicing factors are involved in Mer1p activity that still remain unknown, as do
the steps by which Mer1p is regulating splicing.
The objective of my dissertation is to determine how Mer1p regulates the splicing
of pre-mRNA, containing the Mer1p-enhancer element. The goal of this work is to
elucidate the molecular mechanism of Mer1p activation and to characterize the
interaction between Mer1p and the spliceosome machinery. The results from this work
will help to understand better the role of splicing enhancer elements during the splicing
reaction. The data presented in this work demonstrate that Mer1p recruits U1 snRNP and
U2 snRNP to pre-mRNAs containing the Mer1p-enhancer element and that this process
requires the U1 snRNP protein, Nam8p, and the U2 snRNP protein, Snu17p. These
findings suggest a model of Mer1p-splicing activation by direct interaction and
recruitment of the snRNPs to the pre-mRNA.
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CHAPTER II

EXPERIMENTAL PROCEDURES
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2.1 Splicing Extracts
Splicing extracts were prepared by the liquid nitrogen grinding procedure as
described (Umen and Guthrie 1995) using the wild type yeast strains (KH46 and KH52),
Nam8 deletion (nam8∆) strain, Snu17 deletion (snu17∆) strain, and Bud13 deletion
(bud13∆) strain. These strains carried either a constitutive MER1 expression plasmid,
pRS426FLAGMER1, or empty pRS426 vector. One liter cultures were grown in YEPD
to an O.D. 600 of 2.5-3.5.

Cells were harvested, washed and resuspended in cold

grinding buffer before freezing them in liquid nitrogen. Frozen pellets were grounded to a
fine powder, quick thawed and centrifuged at different speeds to remove ribosome and
other cellular components such as cell wall. Extracts were dialyzed against cold buffer D
(20 mM HEPES, pH 7.9, 50 mM KCl, 0.2 M EDTA, 20% glycerol) for a total of 3 hours
and centrifuged one more time to remove any precipitate. Flash freeze aliquots were
made for future use.
Splicing extracts were analyzed for total protein content by the Bradford protein
assay procedure, measuring the absorbance at 595 nm and then determinating the amount
of protein using a protein standard curve. Splicing activity of the extracts was evaluated
by in vitro splicing reaction.
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2.2 In vitro Transcription Reaction
For in vitro transcription reactions pT7 plasmids were linearized by digestion with
Hind III, Cla I, or Xho I (Figure 2.1). Run off transcripts from Hind III digested
plasmids included the 5’ exon, intron, and 3’ exon; transcripts from Xho I digested
plasmids included the 5’ exon and approximately the first 70 nt of the intron and lacked a
branchpoint sequence; transcripts from Cla I digested plasmids lacked the 3’ splice site,
but contained the branchpoint sequence.

Radiolabeled RNAs for in vitro splicing

reactions and commitment assays were transcribed with T7 RNA polymerase to a specific
activity of approximately 6000 cpm/fmol using pT7 digested with Hind III as a template.
Transcription of biotinylated RNA was performed using a mix of rNTPs with a ratio of
1:6 biotinylated UTP (biotin-16-UTP) versus rUTP. Transcripts were PAGE purified.

Armisen Garrido, Javier, UMSL, 2007 p.50

Figure 2.1

Templates used during in vitro transcription reactions. Plasmid

pT73XAct has three copies of MER1 enhancer element (ACACCCTT). While digesting
the vector with XhoI removes the branch point region and the 3’ splice site, digestion
with ClaI removes only the 3’ splice site from the template.
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2.3 Commitment Assay
In vitro splicing commitment assays were performed in two steps or reactions
(Figure 2.2). During the first reaction, radiolabeled pre-mRNA (from run-off
transcription of Hind III digested plasmid) was incubated with ATP-depleted splicing
extracts containing or lacking Mer1p. ATP was depleted from the extracts by preincubating them with dextrose prior to addition of pre-mRNA. Dextrose is used as a
substrate for hexokinase in the extracts, converting ATP into ADP. After incubation of
the first extract at 23 °C, a second functional extract was added with ATP and a 400-fold
molar excess of unlabeled (cold) competitor pre-mRNA and incubated at 16 °C.
Reactions were then incubated for additional time and terminated by addition of stop
buffer. Radiolabeled RNA was recovered, PAGE analysis and phosphorimaging were
conducted to determine the extent of splicing.
In vitro splicing commitment assays were also performed by inactivating the U2
snRNP instead of depleting ATP. The U2 snRNP was inactivated with an antisense
oligonucleotide specific against the U2 snRNA. The hybrid formed between U2 snRNA
and the oligonucleotide was recognized by the RNase H and therefore degraded. Oligo
was added only before the first step and in quantities that would affect only the first
reaction but not the second.
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Figure 2.2

Commitment assay.
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2.4 RNA Affinity Chromatography Assay
The high affinity and specificity of streptavidin–biotin interactions can be used to
immobilize molecules to a solid support to capture complexes. Using this principle, RNA
affinity chromatography was performed, where the biotin group was incorporated into the
actin pre-mRNA, while the streptavidin group was attached to a solid agarose bead. In
vitro transcribed biotinylated pre-mRNA was incubated with pre-blocked streptavidin
agarose beads. After incubation, beads were washed to remove any unbound biotinylated
pre-mRNA, and splicing extracts, with or without Mer1p, were added to the beads. The
splicing reaction, containing the pre-mRNA attached to the beads and the extracts, was
incubated for 20 minutes before the beads were washed to remove unbound cellular
components. RNA was recovered, followed by EtOH precipitation, and analyzed by
primer extension using specific oligos against U1 snRNA, U2 snRNA, U6 snRNA and
actin pre-mRNA. For ATP depletion, dextrose was added to the reaction prior to addition
to the beads. For snRNA depletion experiments, extracts were pre-incubated with U1 or
U2 antisense oligos and then added to the reaction (Figure 2.3).
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Figure 2.3

RNA affinity chromatography assay.
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2.5 Primer Extension Analysis
Primer extension analyses were used to quantify RNA levels (Figure 2.4)
(Spingola, Armisen et al. 2004). In an initial step, a radiolabeled primer is annealed to the
RNA template in a heat and flash cold process. Then, during the extension step, the
reverse transcriptase recognizes the primer and starting from the 3’ end of the primer
incorporates dNTPs, creating a radiolabeled cDNA copy of the RNA template that ends
at the 5' end of the template molecule. Once the reaction is completed, products are
treated with proteinases and RNases, and the cDNAs are EtOH precipitated and analyzed
by PAGE. Finally, phosphorimaging visualizes the different product sizes, the intensity
of the band is proportional to the amount of initial template in the reaction.
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Figure 2.4

Primer extension analysis.
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CHAPTER III

Mer1p FUNCTION DEPENDS ON
THE CONSERVED U2 snRNP
PROTEIN Snu17p
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3.1 Introduction
There are several types of experimental evidence that support a mechanism of
splicing activation by Mer1p through its interactions with the splicing machinery. For
example, Mer1p co-immunoprecipitates with U1 snRNA, and it forms two-hybrid
interactions with the essential U1 snRNP proteins Snu56p and Snu71p (Spingola,
Armisen et al. 2004). In addition, Mer1p requires the non-essential U1 snRNP protein
Nam8p. Interestingly, Nam8p does not interact directly with Mer1p and its deletion
blocks the ability of Mer1p to activate splicing of introns containing Mer1p-enhancer
element (Spingola and Ares 2000).
In addition to Nam8p, other non-essential splicing factors have been tested for
their ability to regulate Mer1p activity. Several yeast deletion strains for non-essential
snRNP proteins and non-snRNP proteins were tested including the following yeast
strains: snu66∆, ntc20∆ and cdc40∆ as a part of the U4/U5-U6 tri-snRNP complex, lea1∆
and cus2∆ as part of the U2 snRNP; cbp20∆ as a component of the nuclear cap binding
complex; and mud2∆ as part of the CCII. None of these factors showed complete
disruption of Mer1p activity (Spingola, Armisen et al. 2004), and therefore it was
hypothesized that the previous result with nam8∆ was due to a specific effect of the
missing Nam8p, and was not due to a general defect in the stability of the commitment
complex or on spliceosome formation.
During the search for new splicing factors required for Mer1p activity, two new
snRNP proteins were found. Both of them belong to the U2 snRNP particle. The first one,
Prp11p, is an essential splicing factor, that interacts with two additional U2 snRNP
proteins (Prp9p and Prp21p) to form the SF3a splicing factor complex, which is
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necessary for the addition of the U2 snRNP to the pre-mRNA (Ruby, Chang et al. 1993;
Wiest, O'Day et al. 1996). The second factor, Snu17p, is a non-essential U2 snRNP
protein associated with the SF3b complex (Gottschalk, Bartels et al. 2001; Wang, He et
al. 2005), which has also been associated with the RES complex (Dziembowski, Ventura
et al. 2004). Snu17p is required for the first catalytic step of splicing reaction and for the
branch site recognition region during the spliceosome formation.
The results show that while Prp11p presents a strong two-hybrid interaction with
Mer1p, it fails to show any interaction in co-immunoprecipitation experiments,
suggesting the possibility that additional factors could be involved in the Mer1p-splicing
regulation. Moreover, when Prp11p is not a component of the SF3a subunit, it fails to
interact with Mer1p, indicating that the interaction between Prp11p and Mer1p only
occurs in a very specific context. Interestingly, and as occurred with Nam8p, Snu17p
does not make a two-hybrid interaction with Mer1p, but its deletion results in a loss of
splicing activation by Mer1p. Finally, in vivo experiments show that SNU17 deletion does
not have the same effect in all the Mer1p-dependent introns. Indeed, a more severe effect
was observed in the Mer1p activity when the splicing efficiency of AMA1 or MER2 premRNAs was analyzed, compared to the splicing efficiency of MER3, in a snu17Δ
background.
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3.2 Materials and Methods
Yeast strains and plasmids. The yeast strains used for these studies and for
isolating total RNA for primer extension analysis were KH46 (MATα ura3-52 leu2-3 112
trp1-1 lys2 his3-1 ade2-101 cup1D::ura-3±52), gene deletion in BY4741 (MATα his3∆1 leu2-∆0 met15-∆0 ura3-∆0) (Invitrogen) and the temperature sensitive prp11-1 yeast
strain. For the two-hybrid assay, yeast strain L40 (MATα his3∆200 trp1-901 leu2-3112
ade2 LYS2::(4lexAop-HIS3) URA3::(8lexAop-lacZ) GAL4) was used. Yeast strains
KH46 and snu17Δ were co-transformed by the LiOAc method (Hill, Donald et al. 1991)
with the following plasmids: R1070 (constitutively expresses Mer1p) or its parental
empty vector R1130 (gifts from G.S. Roeder described in Engebercht et al., 1991) and
pRS316/cupAMA1-E or pRS316/cupMER2 or pRS316/cupMER3. Yeast strain prp11-1
was co-transformed with pRS426FlagMER1 or its parental empty vector pRS426 and
pRS316/cupAMA1-E.

RNA and Splicing Assays. RNA was isolated from yeast, containing plasmids, by
a glass beads method (Derker and Parker 1993) from 5ml cultures of synthetic complete
dextrose (SCD) medium lacking the appropriate amino acids and/or base. Splicing of
each of the cloned introns in vivo was analyzed by primer extension of total RNA using a
5’ radiolabeled CUP primer, which is complementary to the second exon, followed by
PAGE. Typically, 5–10 µg of total RNA were annealed to 0.2 ng of 5’ 32P-labeled primer
in a 10 µL reaction by first heating the sample to 90 oC for 3 min and then slowly cooling
from 65 oC to 42 oC. To the annealed mix were added 10 µL of 50 mM Tris (pH 8.0), 80
mM KCl, 20 mM MgCl2, 10 mM dithiothreitol (DTT), 0.2 mM dNTP, 100 µg
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actinomycin D, and 20 U of SuperScriptII Reverse Transcriptase (Invitogene). Reactions
were incubated at 42 oC for 60 min and terminated by adding 10 µL of 0.6 M NaOAc (pH
5.0), 60 mM EDTA, 1 mg/mL RNaseA with further incubation for 10 min at 42 oC. To
this were added 10 µL of 0.6 M NaOAc (pH 5.0), 0.2% SDS, 20 mg proteinase K, and
they were incubated for another 10 min at 42 oC. Samples were then precipitated on dry
ice after the addition of 3 volumes of ethanol. Precipitates were centrifuged 5 min at
14,000 rpm, the supernatants were removed, and the pellets were dried. Pellets were
redissolved in 3 µL of water and 3 µL of formamide/20 mM EDTA/0.25% bromophenol
blue and xylene cyanol and then denatured for 5 min at 90 oC. The reverse transcription
products were electrophoresed through 6% polyacrylamide, 7.5 M urea gels. Gels were
dried

and splicing

efficiency was quantitated with

a Molecular

Dynamics

Phosphorimager. Primer extension analysis was performed on duplicate or triplicate
samples. The formula S/(S + U), where S is spliced product and U is unplaced premRNA, was used to calculate splicing efficiency. Primer sequences were specific for
plasmid-encoded mRNA and bind to the CUP1 sequences in the second axon. The CUP1
primer sequence is 5’-GGCACTCATGACCTTCATTTTGG.
RT-PCR was performed in two steps. RNA isolated was first reverse transcribed
into cDNA in a 20 µL reaction by primer extension using CUP1 primer. The reverse
transcription products were amplified by PCR in a 50 µL reaction using the following
cycle: initial step of 5 min at 95 oC, and then twenty-four times 1 min at 95 oC, 1 min at
50 oC, 1 min at 72 oC, with a final step of 7 min at 72 oC and using B+ (5’GGAAGAGCTCATGTCCACTTATCAAGCTCAGGC)
products were analyzed in a 2% agarose gel.

and

CUP1

primers.

PCR
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Two-hybrid plasmids and co-immunoprecipitation assays. The construction of
the U2 snRNP genes in pACT2 plasmids has been described (Pauling, McPheeters et al.
2000; Igel, Wells et al. 1998). The MER1 ORF or activation domain fragment of MER1
was amplified by PCR and ligated in pBTM116 to form pBTM-MER1 or pBTM-AD,
which fuses the LexA DNA binding domain to Mer1p. Colorimetric assays were
performed (Igel, Wells et al. 1998; Pauling, McPheeters et al. 2000) with strain L40
carrying pBTM and pACT2 derivatives after 3-4 days of growth on selective media. Coimmunoprecipitation experiments were performed as described before (Spingola and
Ares 2000) using HA-tagged Prp11p expression plasmid, as well as Flag tagged Mer1p.
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3.3 Results
Snu17p is required for efficient Mer1p activity. Previous work identified the U1
snRNP protein Nam8p as an essential requirement for Mer1p activity. In addition, Mer1p
co-immunoprecipitated with the U1 snRNA (Spingola and Ares 2000) suggesting that
Mer1p could be activating splicing by interacting with several spliceosome components.
In order to identify new splicing factors involved in the regulation Mer1p-activity,
several deletions of non-essential splicing factors were tested for their ability to block
Mer1p activation of splicing (including components of the tri-snRNP and commitment
complex) (Spingola and Ares 2000). Yeast deletion strains were transformed with pMer1
or control vector and the pRS316CUP-AMA1 vector, which had Mer1p-regulated yeast
gene AMA1. RNA was extracted and the splicing efficiencies for AMA1 pre-mRNA were
analyzed by primer extension (Figure 3.1).

None of these gene deletions showed

significant effects on Mer1p-activation splicing (Spingola, Armisen et al. 2004).
Searching for non-essential spliceosome components involved in Mer1p regulation,
additional non-essential U2 snRNP proteins were tested, including Snu17p (Figure 3.2).
Yeast strain snu17∆ was co-transformed with Mer1p expressing vector (R1070) or empty
vector (R1130) and AMA1 expressing plasmid. RNA was isolated and primer extension
was performed using a specific primer against the 3’ region of the transcript. Primer
extension products were separated by PAGE and splicing efficiency was calculated by
the formula S/(S + U). In the absence of Snu17p, Mer1p could not activate the splicing of
AMA1 pre-mRNA. Similar result was obtained when MER2 reporter pre-mRNA was used
instead of AMA1 (Figure 3.2).
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Since the loss of Mer1p activity did not occur with the deletion of the other nonessential U2 snRNP proteins, Cus2p and Lea1p (Figure 3.1) (Spingola and Ares 2000),
this result suggested that, as occurred with Nam8p, the splicing defect was due to a
specific effect of the protein loss and not due to a general defect in spliceosome
formation or stabilization. Surprisingly, snu17∆ partially disrupts Mer1p activity on
MER3 (Figure 3.3). While the AMA1 and MER2 pre-mRNAs splicing activity by Mer1p
was fully dependent on the presence of Snu17p, in MER3 pre-mRNA splicing activity
was not totally defective in a snu17∆ yeast deletion strain (Figure 3.3 and Table 3.1). In
the presence of Snu17p, Mer1p was able to activate splicing up to 15-fold for MER3 premRNA, but in the absence of Snu17p, the splicing activity went down less than half
(Table 3.1). Interestingly, this effect did not take place when, instead of deleting Snu17p,
other splicing factors and non-splicing factors were tested (Bud13p and Pml1p) (Scherrer
and Spingola 2006). In both cases, Mer1p was able to increase the splicing efficiency of
MER3 pre-mRNA similar to the wildtype levels.
This result suggests that Snu17p regulates Mer1p activity and its effect on Mer1p
splicing regulation differ from pre-mRNA to pre-mRNA. Therefore, the regulation of
Mer1p activity could be a combination of effects from the splicing factors and transcript
characteristics.
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Figure 3.1

Splicing efficiencies of the AMA1 reporter pre-mRNA in different

gene deleted yeast strains. The deleted genes were non-essential splicing factors
(Spingola and Ares 2000). Splicing percentage was calculated by the formula: [S/(S +
U)]*100
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Figure 3.2

Snu17p is essential for Mer1p activity in AMA1 and MER2 pre-

mRNAs. Primer extension analysis of AMA1, MER2 reporter mRNAs from SNU17 and
snu17∆ yeast strains containing a MER1 expression plasmid (+ pMER1) or a control
plasmid (-). Percent spliced is reported as the average of several replicate samples
(Spingola, Armisen et al. 2004).
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Figure 3.3

Snu17p loss partially modulates Mer1p activity in MER3 pre-

mRNA. Primer extension analyses of MER3 reporter mRNAs from snu17∆ yeast
containing a MER1 expression plasmid (+ pMER1) or a control plasmid (-). Percent
spliced is calculated by the formula [S/(S + U)]*100.
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Yeast Strain

BY4741
bud13∆
pml1∆
snu17∆
Table 3.1

% RNA Spliced
MER3

MER3 + Mer1p

2.9 +/- 1
1.9 +/- 0.4
1.9 +/- 0.6
4.3 +/- 1.2

44.2 +/- 1.8
25.4 +/- 3.3
25 +/- 3
27.1 +/- 2.8

Splicing
Activation
15.2 fold
13.3
13.2
6.3

In vivo splicing activation of MER3 reporter by Mer1p. Fold

increase levels were determined by dividing the % RNA spliced + Mer1p by % RNA
spliced - Mer1p (from Scherrer and Spingola 2006).

Mer1p must interact with Prp11p within the SF3a subunit to activate splicing.
The study of functional requirements for Mer1p splicing activation identified two snRNP
proteins, the U1 snRNP protein Nam8p (Spingola and Ares 2000) and the U2 snRNP
protein Snu17p. To test for possible protein-protein interactions between Mer1p and U1
and U2 snRNP proteins, two-hybrid assays were performed (Table 3.2). Although Nam8p
and Snu17p were required for Mer1p to activate splicing, there was no detectable twohybrid interaction between Nam8p or Snu17p and Mer1p. Remarkably, two essential U1
snRNP proteins, Snu71p and Snu56p, that were destabilized from the U1 snRNP when
Nam8p was absent (Gottschalk, Bartels et al. 2001), gave a positive signal in the twohybrid assay with Mer1p (Spingola, Armisen et al. 2004). Since Snu71p and Snu56p are
essential splicing factors it is not possible to uncouple their interaction from their
function, and therefore any effect that they could have over Mer1p activity remains
unknown.
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Mer1p also interacted weakly with the U1 snRNP protein Luc7p and two
accessory splicing factors Mud2p and Bbp1p (implicated in recognizing the branchpoint
region prior to the U2 snRNP interaction). Continuing the screening for spliceosome
proteins that interact with Mer1p, several U2 snRNP proteins were tested and,
surprisingly, only intact Prp11p interacted strongly with Mer1p (Table 3.2). A second U2
snRNP protein (Prp9p) that interacts with Prp11p (Legrain and Chapon 1993), also
weakly interacted with Mer1p. Since Prp9p interacts with Prp11p in the SF3a subunit, the
weak two-hybrid signal between Mer1p and Prp9p could be the result of an interaction
that was bridged by Prp11p, as opposed to a direct interaction between Mer1p and Prp9p.
Moreover, since Mud2p and Bbp1p interact with Prp11p, the weak interactions seen
between Mer1p and Bbp1p or Mud2p might also be indirectly mediated by Prp11p
(Legrain and Chapon 1993; Abovich and Rosbash 1997). This hypothesis seems unlikely
since Snu17p is also part of the SF3a complex and did not present any two-hybrid
interaction with Mer1p. Additionally, strong positives from the two-hybrid analysis were
repeated using a bait construct containing the activation domain fragment of Mer1p. The
results mirrored those obtained with the full-length Mer1p (Table 3.2) indicating that the
Mer1p activation domain was the primary mediator of the interactions observed with
these splicing factors. The strong interactions noted by the two-hybrid assays did not
distinguish whether the interactions were direct or mediated by other proteins. To analyze
whether the strong interaction between Prp11p and Mer1p was the result of direct
interaction between the two proteins, co-immunoprecipitation experiments were
performed using HA-tagged Prp11p and Flag-tagged Mer1p to capture any Mer1pPrp11p complex, and anti-flag antibody or polyclonal antibody against Prp11p to detect
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any interaction between Mer1p and Prp11p. Mer1p did not co-immunoprecipitate with
Prp11p. Thus, although two-hybrid interactions do not always reliably predict direct
protein-protein interactions, the two-hybrid results support the hypothesis that Mer1p
interacts with the U1 snRNP proteins, as well as with other components of the
commitment complexes and the pre-spliceosome. In addition, and to further characterize
the interaction between Prp11p and Mer1p, a genetic study was performed using the
temperature sensitive mutant prp11-1. Prp11-1 mutation prevents the association of
Prp11p with the spliceosome (Schappert and Friesen 1991), so it is no longer part of the
U2 snRNP. Moreover, prp11-1 fails to interact with Mer1p during the two-hybrid assay
(Table 3.2). Prp11-1 strain was transformed with the Mer1p expression vector or the
empty vector and with AMA1 expression vector PGE. RNA was isolated at the permissive
temperature and the splicing efficiency of AMA1 was measured by reverse transcriptase
PCR. Even in the presence of Prp11-1p, Mer1p could not activate the splicing of AMA1
(Figure 3.4), suggesting that Mer1p-splicing activation could occur through its
interaction with the splicing machinery and that Prp11p properly associated with the U2
particle is required for Mer1p activity.
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pACT+

Blue intensity with pBTM-MER1

Vector
NAM8
SNU56
SNU71
MER1
U1C
LUC7
MUD2
BBP
CUS1
CUS2
HSH49
HSH155
SUB2
PRP9
PRP11
prp11-1
PRP5
PRP21
SNU17

++
+++
+
+
++
+
++++
Blue intensity with pBTM-AD
++
+++
++++

SNU56
SNU71
PRP11
Table 3.2

Two-hybrid interactions between Mer1p and different splicing

factors. Minus signs indicate no accumulation of blue color. Plus signs indicate
development of blue color with more plus signs corresponding to darker blue color
development (Spingola, Armisen et al. 2004).
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Figure 3.4

RT-PCR of AMA1 splicing products from a prp11-1 yeast strain.

The unspliced AMA1 gene gives a product band of 222nt while the spliced AMA1 gives a
product of 129nt.
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3.4 Discussion
Previous works identified interactions between proteins of the U1 snRNP and
Mer1p (Spingola and Ares 2000; Spingola, Armisen et al. 2004). In fact, two essential U1
snRNP proteins, Snu71p and Snu56p, were identified as strong candidates that interacted
with Mer1p in the two-hybrid assay. Additionally, Mer1p also interacted weakly with the
U1 snRNP protein Luc7p. Surprisingly, the non-essential U1 snRNP protein Nam8p that
was required for Mer1p activity did not present any detectable two-hybrid interaction
with Mer1p. Moreover, several accessory splicing factors (Mud2p and Bbp1p) and U2
snRNP proteins, Prp9p and Prp11p, presented interactions with Mer1p. In this chapter,
we report that only the wild type Prp11p is able to interact with Mer1p, while the
temperature sensitive mutant prp11-1 abolishes such interaction (Table 3.2). Attempts to
confirm direct interaction between Mer1p and Prp11p by co-immunoprecipitation failed,
suggesting that a transient association between both proteins might occur, or that an
additional splicing factor is required for their interaction. Independent of the nature of
association between Mer1p and Prp11p, the two-hybrid interactions support the
hypothesis that Mer1p regulates splicing by interacting with components of the
spliceosome and, therefore, Mer1p could regulate the splicing of Mer1p-dependent
introns at different stages during the spliceosome formation. Moreover, Mer1p cannot
activate splicing without the non-essential U2 snRNP protein Snu17p and, as occurred
with Nam8p, Mer1p does not make two-hybrid interaction with Snu17p. Snu17p enters
splicing complexes as part of the U2 snRNP and is thought to function in spliceosome
assembly after addition of the tri-snRNP but before U1 snRNP release (Gottschalk,
Bartels et al. 2001). A possible metazoan homolog of Snu17p has been identified as p14,
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which can be cross-linked to the pre-mRNA branchpoint nucleotide (Will, Schneider et
al. 2001). When Snu17p is present, U1 and U4 are rapidly displaced from the assembling
spliceosome after the binding of the tri-snRNP. While non-essential, the loss of Snu17p
retards progression of spliceosome assembly and leads to the formation of a complex that
contains all five snRNPs (Gottschalk, Bartels et al. 2001). Hence, Snu17p may be
involved in displacing both the U1 and U4 snRNPs from assembling spliceosomes.

Why does snu17∆ have different effects on specific Mer1p dependent introns?
The splicing efficiency of AMA1 reporter pre-mRNA is greatly affected in the
snu17∆ yeast deletion strain, even in the presence of Mer1p, indicating that in the
absence of Snu17p, Mer1p cannot activate the splicing of AMA1. The same result is
obtained with the MER2 pre-mRNA reporter. Surprisingly, this is not the situation for the
MER3 pre-mRNA reporter, where the deletion of SNU17 only partially prevents Mer1pactivation. Since previous results support the hypothesis of Mer1p interacting at different
stages during spliceosome formation, the difference in Mer1p regulation between MER3
and AMA1 could reflect the different stages at which Mer1p regulates splicing in different
pre-mRNAs. In addition, these results suggest that the splicing regulation of Mer1p is not
entirely dependent on its interaction with the splicing machinery, and that additional
gene-specific elements play an important role in Mer1p function. The study of MER3 and
AMA1 pre-mRNAs reveals two main features that clearly differentiate both pre-mRNAs
(Figure 3.5). While MER3 contains a small 5’ exon, the 5’ exon of AMA1 is very large.
Additionally, MER3 possesses an extremely large 3’ exon compared to the AMA1 3’
exon. These differences in exon size could affect the splicing efficiencies of AMA1 and
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MER3 in a snu17∆ yeast strain when Mer1p is present. It been reported that splicing
efficiency is affected by the extension of the 3’ exon (Turnbull-Ross, Else et al. 1988).
The shorter 3’ exon seems to affect negatively the splicing efficiency, presumably
because of its influence over the second step of the splicing reaction. In this sense, any
effect that Snu17p might have over the early spliceosome complex stability on MER3
transcript could be compensated by a more stable second step due to a larger 3’ exon.
Moreover, the difference in exon size could modulate the timing at which Mer1p is
working and/or affecting specific splicing factors involved in Mer1p-regulation. Different
exon sizes can adopt different spatial conformations and structures, which can result in
differences in spliceosome assembly and therefore different interactions with Mer1p.
Finally, it has been reported that reduction in the large 5' exon of AMA1 increases its
splicing efficiency in a wild type strain and nam8∆ strain, and that MER2 becomes
Mer1p-independent when its 5’ exon is shortened (Nandabalan and Roeder 1995;
Spingola and Ares 2000). Since the cap-binding complex (CBC) increases the efficiency
and stability of the U1 binding to the pre-mRNA, and it is able to interact directly with
Mud2p (Lewis, Izaurralde et al. 1996), maybe a shorter 5’ exon would increase the
interaction between CBC and the different splicing complexes making them more stable
and able to overcome any destabilizations caused by the disruption of SNU17 gene.
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Figure 3.5

Schematic representation of AMA1, MER2, and MER3 genes.
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4.1 Abstract
In the yeast Saccharomyces cerevisiae Mer1p is expressed only during meiosis and
regulates the splicing of at least three mRNAs: AMA1, MER2, and MER3. In vitro,
Mer1p increases the levels of snRNAs bound to pre-mRNA. This increase is dependent
on the nonessential U1 snRNP protein Nam8p and the Mer1p intronic enhancer, but not
on a 5’ splice site-U1 snRNA interaction.

Mer1p also recruits the U2 snRNP to

commitment complexes without a requirement for the branchpoint sequence or ATP
hydrolysis. Surprisingly, the inactivation of U2 snRNP reduced the ability of Mer1p to
enhance the binding of U1. Time course experiments indicate that Mer1p increases the
rate of U1 snRNA binding to pre-mRNA, and commitment assays show that Mer1p
regulates splicing prior to hydrolysis of ATP. These data indicate that the Mer1p splicing
regulator functions early in the spliceosome assembly pathway by recruiting snRNPs to
pre-mRNA and stabilizing early splicing complexes involving U1 and U2.

4.2 Introduction
In the yeast Saccharomyces cerevisiae, the vast majority of mRNA splicing
occurs constitutively and is not regulated. Only a handful of genes contain multiple
introns or are alternatively spliced (Spingola et al., 1999; Davis et al., 2000). This is in
contrast to human primary transcripts, which almost exclusively contain multiple introns
whose alternative splicing must be tightly controlled (Croft et al., 2000). Nonetheless,
splicing of some introns in yeast is regulated, and these introns provide an ideal system to
study the mechanism of splicing regulation in a highly tractable system. For example,
during prophase I of meiosis the splicing regulator Mer1p is produced in the yeast
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Saccharomyces cerevisiae (Engebrecht et al., 1991).

This protein contains an

evolutionarily conserved KH domain RNA binding motif (Siomi et al., 1993) and
activates the splicing of at least three genes: AMA1, MER2, and MER3 (Engebrecht et
al., 1991; Nakagawa & Ogawa, 1999; Davis et al., 2000). Proteins produced from the
spliced mRNAs of each of these three genes are essential for the completion of meiosis
and the development of viable spores. Without Mer1p, these pre-mRNAs are poorly
spliced and spores are inviable.
Splicing occurs in the nucleus and involves over one hundred proteins and five
small nuclear RNAs (snRNAs) (reviewed in Staley & Guthrie, 1998; Brow, 2002; Jurica
& Moore, 2003; Butcher & Brow, 2005). These snRNAs bind several proteins to form
five small nuclear ribonuclear protein particles (snRNPs) called U1, U2, U4, U5, and U6.
In vitro, these snRNPs bind to pre-mRNA in a specific order to form a mature
spliceosome (Pikielny et al., 1986; Cheng & Abelson, 1987). However, a penta-snRNP
has also been isolated from yeast and shown to be active in vitro as well, suggesting that
in vivo a holoenzyme might be recruited to introns (Stevens et al., 2002).

Recent

chromatin immunoprecipitation studies support the sequential accretion model for
spliceosome assembly in vivo (Gornemann et al., 2005; Lacadie & Rosbash, 2005;
Tardiff & Rosbash, 2006).

In this model, first U1 snRNP binds to pre-mRNA to form

the commitment complex (CC) (Seraphin & Rosbash, 1989). The formation of this
complex involves base pairing between the 5’ splice site sequence of the pre-mRNA and
the 5’ end of U1 snRNA (Seraphin et al., 1988) and involves the interactions of several
snRNP proteins with the intron (Puig et al., 1999; Zhang & Rosbash, 1999). The U2
snRNP binds to the CC to form the pre-spliceosome (PS) (Perriman & Ares, 2000).
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Formation of the PS relies on the base pairing of the intronic branchpoint sequence (bps)
with the bps interacting sequence (bpis) on U2 snRNA as well as snRNP protein-intron
interactions (Parker et al., 1987). Several negative splicing regulators, most notably the
Drosophila PSI protein and yeast RPL30 protein, function at these early stages (Siebel et
al., 1992; Siebel et al., 1994; Vilardell & Warner, 1994). After formation of the PS, the
remaining snRNPs bind as a tri-snRNP.

Structural rearrangements ensue U1 to be

released from the assembly, U4 to unwind from U6 snRNA, and U2 to base pair with U6
snRNA.

At this stage, U6 base pairs to the 5’ splice site.

The transesterification

reactions that are catalyzed by the spliceosome now occur: first the 2’ hydroxyl of the
branchpoint nucleotide reacts with the 5’ splice site to generate a free 5’ exon and lariat
branched intron that is still connected to the 3’ exon. Then the 3’ hydroxyl group of the
5’ exon reacts with the 3’ splice site to connect the two exons and to excise the intron in a
lariat form.
The molecular mechanisms underlying positive splicing regulation remain largely
unknown.

Generally, positive regulation, or activation of splice sites, is thought to

involve the recruitment of snRNPs or accessory splicing factors to splice sites by
regulators that are bound to the pre-mRNA (reviewed in Black, 2003). This facilitates
the formation of active spliceosomes that select splice sites that would otherwise not be
selected. It remains unknown when during spliceosome assembly or during the splicing
reactions that regulation can or cannot occur and what spliceosome assembly
intermediates can or cannot be targets for regulating splicing. In these studies we use
RNA affinity chromatography assays and commitment assays to analyze the function of
Mer1p in vitro.

We show that Mer1p accelerates the formation of commitment

Armisen Garrido, Javier, UMSL, 2007 p.85
complexes and increases their stability. Mer1p can only recruit and stabilize the binding
of snRNAs to pre-mRNA if the nonessential U1 snRNP protein, Nam8p, and the Mer1p
intronic splicing enhancer element are present. Moreover, we show that Mer1p can also
recruit the U2 snRNP to pre-mRNA lacking a branchpoint sequence and without ATP
hydrolysis. Surprisingly, the loss of functional U2 reduced the ability of Mer1p to recruit
U1, suggesting that U1 and U2 may be simultaneously recruited to pre-mRNA by Mer1p
or that the binding of U2 stabilizes the commitment complex. These data indicate that a
cell-cycle specific regulator controls splicing by promoting the formation of and
increasing the stability of early splicing complexes that involve U1 and U2 snRNPs.
Moreover, Mer1p must be able to interact with U1, U2, and the intronic enhancer element
to activate the formation of spliceosomes.

4.3 Results
Mer1p increases the amount of snRNAs bound to enhancer-containing premRNA. Previously we had demonstrated that Mer1p can co-immunoprecipitate U1
snRNA (Spingola & Ares, 2000). While this implies that Mer1p activates splicing by
interacting with the U1 snRNP, it does not demonstrate that Mer1p facilitates the binding
of U1 to pre-mRNA to form commitment complexes. Here we have utilized RNA
affinity chromatography, to demonstrate that Mer1p increases the amount of snRNAs that
bind to pre-mRNA. In previous studies we have shown that Mer1p can activate the
splicing of an actin pre-mRNA that has been altered to contain a Mer1p enhancer element
(ACACCCUU) and a weakened 5’ splice site (GTTCGT or GTATAT, underlined nts
deviate from wild type sequence GTATGT) in vivo (Spingola & Ares, 2000; Spingola et
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al., 2004).

A biotinylated derivative of these RNAs that contains three repeats of the

enhancer element with a wild type 5’ splice site sequence and branchpoint sequence, but
lacking a 3’ splice site and second exon, was transcribed in vitro (bt-3X-Act pre-mRNA).
Previous work has shown that Mer1p rescues a variety of splicing defects: weak 5’ splice
sites, large 5’ exons, weak branchpoint sequences, and even a intronic splicing silencer
(Nandabalan et al., 1993; Nandabalan & Roeder, 1995; Spingola & Ares, 2000; Spingola
et al., 2004). We chose the 3X-Act construct with a wild-type 5’ splice site for affinity
assays because it splices in vitro and binds snRNAs, whereas 3X-Act with a 5’ splice site
mutation does neither (not shown).
Bt-3X-Act pre-mRNA was immobilized on streptavidin-agarose beads and then
incubated with splicing extracts that were prepared from haploid cells that either
contained or lacked a plasmid for the constitutive expression of MER1. After washing
unbound extract off the beads, bound snRNAs were eluted and analyzed by primer
extension and PAGE. To compare the amounts of bound snRNAs in each reaction, any
variability in agarose beads and RNA recovery during the wash and elution steps must
first be considered. Hence, the bands in each lane of a gel were normalized to the actin
recovery band in the same lane by taking the ratio of the snRNA band to the actin band.
After this correction to account for minor differences in RNA recovery from the beads,
the fold-increase of snRNA binding by Mer1p can made by taking the ratio of
snRNA/actin with Mer1p to snRNA/actin without Mer1p. The results in Figure 4.1A
indicate that extracts that contained Mer1p led to more U1, U2 and U6 snRNAs binding
to the immobilized pre-mRNA. Mer1p reproducibly caused a 2-3-fold increase in the
levels of snRNAs bound to the pre-mRNA. Similar results were also obtained with a
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biotinylated AMA1 pre-mRNA (data not shown). Background binding of snRNAs to
beads is common in RNA affinity experiments with yeast pre-mRNAs (Ruby et al.,
1990), even after stringent washing. Although the levels of snRNAs bound to premRNA-coated beads are not dramatically higher than background, the signals are
consistently above background and the increase in snRNAs bound to Mer1p is very
reproducible.
The results shown in Figure 4.1A do not distinguish whether Mer1p recruits all of
the snRNAs or just U1 snRNA to the pre-mRNA, which is required for subsequent
binding of U2 and U6. Furthermore, these results do not distinguish whether Mer1p
increases the rate of binding of these snRNAs or if it stabilizes the binding of these
snRNPs, which in turn allows higher order splicing complexes to form.

These

possibilities are addressed later.
To reduce any variability between splicing extracts, isogenic strains were used
that differed only by the constitutive expression of MER1. Cultures of the two strains
were grown simultaneously to identical cell densities, and extracts were prepared side-byside. Then they were tested to show that (1) they contain the same amounts of snRNAs
by primer extension (for example see lanes 1-2 of Figure 4.1A), (2) they have the same
amount of total protein by a Bradford protein assay (data not shown), and (3) they have
equivalent splicing activity on Actin pre-mRNA by a standard in vitro splicing assay (Lin
et al., 1985) (data not shown).
As an important control to verify that the increased binding of snRNAs to premRNA was to due to Mer1p in the extracts, we tested whether extracts containing Mer1p
would increase the binding of snRNAs to a similar pre-mRNA that lacked a Mer1p
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enhancer element. To this end, bt-Act transcripts, which are identical to bt-3X-Act
transcripts except that they lack the triple repeat of the enhancer element, were employed
in the RNA affinity assay. Figure 4.1B shows that the ability of extracts with Mer1p to
increase binding of snRNAs to pre-mRNA was abolished if the pre-mRNA lacked the
enhancer element.

In vitro, the Mer1p-dependent increase in snRNAs bound to

immobilized bt-3X-Act pre-mRNA is dependent on Mer1p and on the enhancer element.
Since the enhancer element is necessary and sufficient for Mer1p-activated splicing in
vivo (Spingola & Ares, 2000), the dependence of the enhancer for Mer1p function in vitro
is a good indication that our in vitro conditions sufficiently mimic in vivo conditions with
regards to studying the function of Mer1p.

Mer1p recruits U1 and U2 snRNA to pre-mRNA that lacks a branchpoint
sequence. While the majority of experimental analysis on Mer1p functions implicates the
U1 snRNP, some data have implicated the U2 snRNP: Mer1p interacts with the U2
protein Prp11p in two-hybrid experiments, Mer1p can rescue splicing defects that are
caused by branchpoint sequence mutations, and Mer1p cannot activate splicing without
the nonessential U2 snRNP protein Snu17p (Gottschalk et al., 2001; Wang & Rymond,
2003; Spingola et al., 2004; Wang et al., 2005), which is also a subunit of the RES
Retention and Splicing complex (Dziembowski et al., 2004; Scherrer & Spingola, 2006).
Recognition of the branchpoint sequence is thought to be mostly a function of U2 since
the branchpoint sequence forms base pairs with U2 snRNA (Parker et al., 1987), although
the branchpoint sequence is also recognized in the context of the commitment complex
by two accessory proteins in yeast, Msl5p (the Branchpoint Binding Protein) and Mud2p,
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prior to the binding of U2 snRNP (Abovich & Rosbash, 1997; Berglund et al., 1997).
When these two accessory factors bind to the commitment complex, they form CC II, and
they are displaced when U2 binds (Rutz & Seraphin, 1999). Despite the evidence above
implicating U2 function for Mer1p-activated splicing, the Mer1p co-immunoprecipitate
does not include U2 snRNA (Spingola & Ares, 2000). Although this result could be
explained if binding of U2 to the CC blocked the binding of anti-Mer1p antibody, or if a
Mer1p-U2 interaction were not stable enough to withstand the wash steps, we sought
additional proof that Mer1p function directly involves the U2 snRNP. Since the RNA
affinity chromatography experiments indicated that Mer1p increases the binding of
several snRNAs to pre-mRNA, we originally sought to design a pre-mRNA that would
only bind U1 snRNA.

A pre-mRNA was designed that was truncated prior to the

branchpoint sequence (Xho-bt-3X-Act). This shortened transcript includes the 5’ exon,
the 5’ splice site and the enhancer element repeat, but no branchpoint sequence or 3’
splice site. Surprisingly, when this RNA was subjected to RNA affinity chromatography,
extracts containing Mer1p led not only to increased levels of bound U1, but also U2
(Figure 4.2A).

There are at least two interpretations of these data:

the increased

abundance of U2 could simply be the result of increased U1 since U2 cannot bind to premRNA without U1 bound, or Mer1p can directly recruit U2 to commitment complexes.
The latter is consistent with the observation that Mer1p interacts with the U2 snRNP
protein Prp11p. If the increased binding of U2 were solely the consequence of higher U1
binding, one might also predict increased U6 binding, which was not observed. In either
event, Mer1p leads to an increase in the binding of both U1 and U2, but not U6, to a premRNA that lacks a branchpoint sequence.
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Without the branchpoint sequence, Mer1p’s ability to increase the amount of U2
snRNA bound is slightly reduced (from 2.52 fold to 1.78 fold) indicating that the binding
of U2 to pre-mRNA containing a branchpoint sequence is more stable. Interestingly,
without the branchpoint sequence, Mer1p does not recruit as much U1 snRNA either.
The increase due to Mer1p decreases from 3.6-fold to 1.8-fold when the bps is deleted.
This could be because Msl5p and Mud2p cannot bind to this RNA to contribute stability
to the commitment complex, or possibly because the binding of U2 affects the stability of
U1. The possibility that U2 binding influences the binding of U1 is explored later.

Recruitment of the U2 snRNP to pre-mRNA by Mer1p does not require ATP.
Normally, the addition of U2 snRNP to the CC requires ATP hydrolysis (Perriman &
Ares, 2000). Although the role of ATP in pre-spliceosome formation is still debatable,
recent data suggest that Prp5p must hydrolyze ATP for the stable addition of U2 at the
branchpoint sequence (Perriman et al., 2003) and that the ATP-imposing region of a premRNA is immediately upstream of the branchpoint sequence (Newnham & Query, 2001;
Xu et al., 2004). Since Xho-bt-3X-Act RNA lacks a branchpoint sequence and its
adjacent 5’ region, ATP should not be necessary for the addition of the U2 snRNP to
commitment complexes that include Mer1p. RNA affinity experiments using Xho-bt3X-Act RNA confirm this prediction (Figure 4.2B). Extracts containing Mer1p lead to
an increase in U2 snRNA bound to pre-mRNA that lacks a branchpoint sequence even
when ATP has been depleted from the splicing extract by the addition of dextrose
(compare lanes 2-3). The addition of dextrose to 0.2mM efficiently depletes any ATP in
the extract by providing a substrate for hexokinase in the extracts and inhibits splicing
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(see lanes 3-4 of Figure 4.6) These data imply that the base pairing between U2 snRNA
and the branchpoint sequence is not required for U2 snRNP to be added to commitment
complexes that include Mer1p, and that Mer1p could be activating splicing by facilitating
the formation of early splicing complexes that form prior to the hydrolysis of ATP but
include U1 and U2.

Loss of the Nam8p U1 snRNP protein abolishes the ability of Mer1p to increase
the binding of snRNAs to pre-mRNA. Without the integral U1 snRNP protein Nam8p,
Mer1p cannot activate splicing in vivo, and the inability to efficiently splice Mer1pdependent introns leads to inviable spores (Nakagawa & Ogawa, 1997, 1999; Spingola &
Ares, 2000). Nam8p has three RNA recognition motifs, cross-links to pre-mRNA just
downstream of the 5’ splice site, is important for splicing introns with weak 5’ splice site
sequences, and stabilizes commitment complexes on pre-mRNAs lacking caps
(Gottschalk et al., 1998; Puig et al., 1999; Zhang & Rosbash, 1999). Nam8p is not
essential for viability, and its loss has very little effect on splicing of most introns (Clark
et al., 2002), other than those regulated by Mer1p. The loss of other nonessential U1
snRNP proteins does not affect Mer1p-activated splicing, indicating that there is a
specific role for Nam8p in Mer1p function. U1 snRNPs prepared from nam8Δ cells have
increased electrophoretic mobility and are deficient in two essential U1 proteins, Snu71p
and Snu56p (Gottschalk et al., 1998). Our hypothesis is that Nam8p contributes stability
to the commitment complex only on specific pre-mRNAs that are poorly spliced. We
propose that Mer1p activates splicing by stabilizing commitment complexes on
inefficiently spliced pre-mRNAs that do not interact strongly with U1 in vivo, and
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furthermore, that the combined free energies contributed by both Mer1p and Nam8p are
required to sufficiently stabilize the commitment complex for further assembly into an
active spliceosome. In the absence of Nam8p, commitment complexes are too unstable
on Mer1p-dependent introns for Mer1p to sufficiently stabilize the commitment complex
to promote rapid assembly into an active enzyme. To begin testing this hypothesis, we
have asked whether Mer1p can increase the binding of snRNAs to immobilized premRNA in the absence of Nam8p. The results from this RNA affinity assay are displayed
in Figure 4.3. Without Nam8p the levels of bound U1 and U2 are significantly reduced,
and there is no difference in bound snRNA levels with or without Mer1p. This suggests
that Nam8p can stabilize the binding of U1 to pre-mRNAs, and that this stabilization is
necessary for Mer1p to function. Moreover, since the amount of U2 bound is also much
lower with the nam8Δ extracts, the recruitment of U2 by Mer1p is also directly or
indirectly dependent on Nam8p.

Disrupting base pairs between U1 snRNA and pre-mRNA does not block the
ability of Mer1p to increase the binding of U1 or U2 snRNPs. To determine whether the
loss of Mer1p-enhanced binding of U1 and U2 snRNA to pre-mRNA with nam8Δ
extracts was specifically due to the loss of Nam8p or a general feature of weakened U1
snRNPs or commitment complexes, the RNA affinity assay was repeated using extracts
with a truncated U1 snRNA lacking the nucleotides that form base pairs to the 5’ splice
site. Previous experiments have shown that base pairing between U1 snRNA and premRNA is not essential for the formation of CC, but that the CC is much less stable
without these interactions (Du & Rosbash, 2001). In order to disrupt the 5’ splice site-U1
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snRNA base pairing interaction, extracts were treated with a synthetic DNA
oligonucleotide that is complementary to the 5’ end of U1 snRNA, which base pairs to
the 5’ splice site, and leads to its RNAse H-mediated degradation. Remarkably, treated
extracts containing Mer1p retained the ability to increase the binding of U1 snRNP or U2
snRNPs to pre-mRNA (Figure 4.4). When Mer1p is present, the levels of truncated U1
bound to pre-mRNA are slightly reduced compared to intact U1 snRNA - about a twofold
increase of truncated U1 versus a 3.5-fold increase of full-length U1 by Mer1p. Levels of
bound U2 are also increased by Mer1p when the base pairing between U1 and the intron
is disrupted, although the values are reduced to less than twofold.

However, the

truncation of U1 snRNA was not complete in this experiment, and it is possible that the
recruitment of U2 by Mer1p measured in this experiment is a function of the residual
full-length U1. We conclude that Mer1p can increase/stabilize the binding of U1 to premRNA without the base pairing interaction between U1 and the 5’ splice site.

Mer1p accelerates the formation of commitment complexes. We propose that
Mer1p increases the equilibrium constant (Keq) for one or more early-forming splicing
complexes; in particular, the commitment complex and pre-spliceosome. The Keq is
determined by the ratio of association to dissociation rate constants (ka/kd). Hence,
Mer1p could affect the equilibrium constant for an early splicing complex by either
increasing its rate of formation (increasing ka) or decreasing its rate of dissociation (kd ),
or some combination of each. To test whether Mer1p affects the rate of formation of
commitment complexes, we measured the binding of U1 to pre-mRNA over time using
the RNA affinity assay. The results are presented in Figure 4.5. The data from samples
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containing or lacking Mer1p were first normalized as in Figure 4.1. Then the data were
normalized to the maximum amount of U1 bound and plotted over time. When Mer1p is
present, greater amounts of U1 bind more rapidly to the pre-mRNA. From minutes 1020, a significant increase in the amount of bound U1 is apparent when Mer1p is present.
We conclude from these analyses that Mer1p can increase the equilibrium constant of the
commitment complex at least in part by increasing the association rate constant for U1
binding to pre-mRNA.

Mer1p commits pre-mRNA to splicing prior to ATP hydrolysis. Commitment
assays have been used to demonstrate that a particular splicing factor or regulator can
stabilize the binding of snRNPs to pre-mRNA to elicit splicing. In a typical commitment
assay, radiolabeled pre-mRNA is first incubated with splicing regulator protein to allow
the regulator to bind to the pre-mRNA. Then splicing extracts are added in conjunction
with excess unlabeled pre-mRNA, and the amount of splicing is measured by PAGE. In
the absence of splicing activator protein, labeled and unlabeled pre-mRNAs compete for
the same limiting splicing factors in the extract, and the vast excess of unlabeled premRNA out-competes the radiolabeled pre-mRNA for these factors. Fewer molecules of
radiolabeled mRNA get spliced than if no competitor was added.

However, if the

splicing activator protein has bound to the pre-mRNA prior to the addition of competitor
and splicing extract, it gives these pre-mRNAs an advantage over the competitor premRNAs for binding snRNPs and splicing. The radiolabeled mRNA with bound regulator
is preferentially chased into active splicing complexes over competitor RNA. This assay
has been used to show that SR proteins are limiting splicing factors that commit pre-
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mRNAs to splicing (Fu, 1993), and that pre-mRNAs are committed to splicing when U1
snRNP binds, prior to the binding of U2 (Legrain et al., 1988; Seraphin & Rosbash,
1989). We have adopted a similar strategy to determine if Mer1p can stabilize the
binding of U1 and commit the pre-mRNA to splicing prior to U2 function. First, extracts
are depleted of ATP by adding dextrose, which provides a plentiful substrate for
hexokinase in the extracts. Treatment with dextrose inhibits splicing (See lanes 3-4 of
Figure 4.6) but does not affect the formation of commitment complexes, which do not
require ATP (Legrain et al., 1988) nor the ability of Mer1p to recruit U1 and U2 to the
pre-mRNA (see Figure 4.2B).

After ATP depletion, the extracts are added to

radiolabeled 3X-Act pre-mRNA. As indicated by the RNA affinity experiments, U1 and
U2 will bind to the pre-mRNA at this stage, but further assembly into an active
spliceosome is stalled without ATP. After a short incubation, a second extract is added
along with ATP and excess unlabeled pre-mRNA to chase the reaction to completion.
After PAGE analysis, splicing is analyzed by measuring the relative amount of lariat
product and lariat-second exon intermediate that form. By this method, Mer1p provides
about a twofold activation of splicing (see Figure 4.6). Without dextrose treatment, very
little difference in the amount of lariats formed can be seen with extracts that contain or
lack Mer1p (lanes 5-6 of Figure 4.6). However, with dextrose treatment of the first
extract, about twice as many lariats form after addition of a second functional extract and
competitor RNA if Mer1p is included in the first extract (lanes 1-2). These results
suggest that Mer1p commits pre-mRNA to splicing by stabilizing early splicing
complexes prior to the hydrolysis of ATP and base pairing of U2 snRNP to the
branchpoint sequence.
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Inactivation of the U2 snRNP reduces the ability of Mer1p to increase U1
snRNA binding. To analyze only the binding of U1 snRNA to pre-mRNA, we treated
extracts with an anti-sense oligo that base pairs to the branchpoint interaction sequence of
U2 to inactivate U2 in extracts and then performed RNA affinity chromatography.
Surprisingly, the inactivation of U2 reproducibly led to decreased recruitment of U1
snRNA by Mer1p. In Figure 4.7, the amount of intact U2 is reduced by 80% (see lanes
1-4) by anti-sense treatment, and Mer1p only leads to a 1.4 fold increase in U1 snRNA
bound to pre-mRNA as opposed to 2-3 fold when U2 is intact (compare lanes 6-8). The
levels of total U1 in the extract are unchanged by treatment with the U2 anti-sense oligo
(lanes 1-4). These results suggest that Mer1p’s ability to recruit or stabilize the binding
of U1 relies on U2. Additionally, Figure 3 shows the recruitment of U2 is dependent on a
U1 snRNP that includes Nam8p. These observations suggest that Mer1p must interact
with U1, U2 and pre-mRNA simultaneously to activate splicing.

4.4 Discussion
We have developed assays that measure Mer1p’s effect on the splicing process in
vitro. While the traditional in vitro splicing assay with radiolabeled 3X-Act RNA and
splicing extracts does not routinely show reproducible differences due to Mer1p, the
RNA affinity assay results in highly reproducible differences in snRNP binding due to
Mer1p.

With the RNA affinity and commitment assays we demonstrate that Mer1p

affects the binding of snRNPs to pre-mRNAs and commits or stabilizes early splicing
complexes in vitro. Although the addition of highly purified recombinant Mer1p to
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splicing extracts has advantages over extracts produced from cells expressing Mer1p,
recombinant Mer1p produced in bacteria is very difficult to keep soluble. Nonetheless,
with extracts that contain endogenously produced Mer1p and the RNA affinity and
commitment assays, Mer1p activity in vitro faithfully reproduces its in vivo activity.
Both in vivo and in vitro Mer1p function relies on Nam8p and on the presence of the
intronic enhancer element.
The differences in snRNA binding and splicing commitment between extracts that
contain or lack Mer1p are likely to be directly due to Mer1p and not a downstream effect
of Mer1p, e.g., the production of a another splicing factor whose mRNA requires Mer1p
for splicing. There are only a few genes for splicing factors that contain an intron, and
none of these has the signature Mer1p enhancer element or is regulated by Mer1p. Of all
the

currently

annotated

introns

in

the

Ares

Lab

Yeast

Intron

Database

(http://metarray.ucsc.edu/cgi-bin/intron/yirIntrondb), only three genes contain a Mer1pactivatable intron, and each of these genes is directly involved in meiosis, not splicing.
Therefore it is unlikely that extracts containing endogenously produced Mer1p also
contain an additional splicing factor whose expression or activity relies on Mer1p and is
responsible for the activities that we are attributing to Mer1p in the above experiments.
In corroboration of this, the effects on splicing and spliceosome assembly that we are
attributing to Mer1p rely on a pre-mRNA substrate that contains an intact enhancer
element. We have already shown that Mer1p specifically binds to RNA containing this
element, and it seems unlikely that Mer1p would activate the splicing of an unknown
splicing factor that also binds to the enhancer element of our pre-mRNA substrate. For
these reasons, we believe the effects on splicing in our assays are directly due to Mer1p.
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A mechanism for Mer1p regulated splicing is beginning to emerge from these
studies in which Mer1p activates splicing by overcoming a rate-limiting step in the
formation of active spliceosomes. In the case of a Mer1p-regulated intron, the ratelimiting step in the splicing process is most likely the formation of a splicing complex
that includes pre-mRNA, Mer1p, U1, and U2. Mer1p activates spliceosome assembly
through a combination of increasing the rate of formation of early splicing complexes and
by stabilizing these complexes sufficiently for continued assembly into an active
spliceosome. Time course analysis of snRNAs binding to pre-mRNA indicates that
Mer1p increases the velocity at which the first snRNP, U1, binds to the pre-mRNA. In
addition to increasing the rate of binding, Mer1p stabilizes the binding of U1 and U2 to
the pre-mRNA as indicated by commitment assays. Without Mer1p, the rate of binding
of snRNPs and the stability of the complexes that do form are too low for efficient
spliceosome assembly and splicing.

In order to activate splicing, Mer1p must

simultaneously interact with the intronic enhancer element, U1 snRNP, and U2 snRNP.
Disrupting anyone of these interactions by deleting the enhancer element, deleting
Nam8p, or inactivating U2 has the effect of preventing any increased snRNA binding by
Mer1p, suggesting that all three interactions must occur simultaneously in order for
Mer1p to activate splicing.
Splicing activation may be most readily accomplished during the initiation stages
of spliceosome assembly. It would be more economical to regulate splicing prior to the
expenditure of ATP. Detailed mechanisms of splicing activators are scarce with the
exception of Mer1p, the Drosophila Transformer protein, and the mammalian TIA-1
protein. Transformer is expressed only in female flies, and it forms a complex with the
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Transformer 2 protein.

This complex binds specifically to an exonic purine-rich

enhancer found on at least two pre-mRNAs, Doublesex and Fruitless. When bound to
these enhancers, specific members of the SR protein family of splicing regulators are
recruited and the formation of commitment complexes is enhanced (Tian & Maniatis,
1992, 1993; Lynch & Maniatis, 1996). In the case of Dsx pre-mRNA, the regulatory
complex helps select a female-specific 3’ splice site (Baker, 1989), whereas with Fru premRNA the complex helps select a female-specific 5’ splice site (Ryner et al., 1996;
Heinrichs et al., 1998). Although yeast lack obvious members of the SR family (Mud2p
is the closest homolog of an SR protein), Mer1p, like Transformer, regulates splicing in
the initial stages of spliceosome assembly and activates a meiosis-specific 5’ splice site.
TIA-1 is an animal splicing factor that is homologous to the yeast Nam8p (Del
Gatto-Konczak et al., 2000; Forch et al., 2000). However, unlike Nam8p, TIA-1 is not an
integral U1 snRNP protein, but rather an accessory U1 protein. TIA-1 binds to a U-rich
region of introns just downstream of the 5’ splice site (Forch et al., 2000), and coimmunoprecipitates the U1-C protein of the U1 snRNP (Forch et al., 2002). These
observations suggest that TIA-1 may regulate splicing by binding adjacently to a 5’ splice
site and recruiting U1 snRNP to the 5’ splice site by a protein interaction with U1-C.
Mer1p seems to function in a similar manner to TIA-1, but recruits and stabilizes both U1
and U2.
In contrast, negative splicing regulators are known to function at various stages of
spliceosome assembly and splicing. Several, like the Drosophila PSI or yeast Rpl30p
function early in the assembly of spliceosomes (Siebel et al., 1992; Siebel et al., 1994;
Vilardell & Warner, 1994) by binding the U1 snRNP to a pseudo-5’ splice site or by
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preventing the binding of U2, respectively. Others like the Drosophila Sex lethal protein
have been shown to function after the first step of splicing and regulate the second step
and 3’ splice site selection (Lallena et al., 2002). There are too few mechanistic details
and studies on splicing activators at this date to conclude that their function is limited to
either the initial stages of spliceosome assembly or the second transesterification reaction.

4.5 Materials and Methods
Plasmids and yeast strains. The following yeast strains were used for extract
preparations:

KH46 (MATa, leu2-3, 112, ura3-52, trp1-1, his3-1, lys2D, ade2-101,

cup1D::ura3-52), and nam8Δ (MATa, ura3-52, leu2-3,112, trp1, lys2D, his3-1, ade2101, cup1D::ura3-52, nam8::HIS3). These strains either carried a constitutive MER1
expression plasmid, pRS426FLAGMER1, or empty pRS426 vector. Plasmid pT73XAct
has three copies of the MER1 enhancer element (ACACCCTT) beginning at nucleotide
25 of the actin intron and was constructed by site-directed mutagenesis of pT7Act.

Splicing extracts and RNA transcription. Splicing extracts were prepared from
KH46, or nam8Δ by the liquid nitrogen crushing procedure (Umen & Guthrie, 1995).
pT7 plasmids were linearized by digestion with Hind III, Xho I, or Cla I. Run off
transcripts from Hind III digested plasmids include the 5’ exon, intron, and 3’ exon;
transcripts from Xho I digested plasmids include the 5’ exon and approximately the first
70 nt of the intron and lack a branchpoint sequence; transcripts from Cla I digested
plasmids lack the 3’ splice site, but contain the branchpoint sequence. Radiolabeled
RNAs for in vitro splicing reactions and commitment assays were transcribed with T7
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RNA polymerase to a specific activity of approximately 6000 cpm/fmol. Transcription
of biotinylated RNA was performed in 50 ml reactions with 2 mM ATP, GTP, UTP, 1.7
mM UTP, 0.3 mM biotinylated UTP (biotin-16-UTP, Roche), 40 mM Tris pH 7.9, 12
mM MgCl2, 2 mM spermidine, 20 mM DTT, 1mM NaCl, 100 units of T7 RNA
polymerase, and 1 unit of RNasin. Transcripts were PAGE purified.

RNA affinity chromatography and primer extension analysis. For a 50 ml
reaction, 20 ml of a 50% slurry of streptavidin-agarose beads (Invitrogen) were used.
Beads were blocked three times with 5 volumes of Blocking Buffer (Binding Buffer with
0.05% NP-40 and 2 mg/ml Heparin) and washed three times with 5 volumes of Binding
Buffer (5 mM Tris pH 7.5, 0.5 mM EDTA, 1 M NaCl) before the addition of biotinylated
RNA. 0.2 mg of biotinylated RNA (transcribed from Cla I or Xho I digested plasmids)
was bound to the 20 ml beads in 100 ml of Binding buffer for 1 hour with gentle mixing
at 4° C. The beads were then washed twice with 5 volumes of Buffer D (20 mM HEPES,
pH 7.9, 50 mM KCl, 0.2 M EDTA, 20% glycerol) to remove unbound biotinylated RNA.
10 ml splicing extract, 10 ml 5X splicing buffer, 1 ml 100 mM ATP and 9 ml water were
added to the bed of beads. The mixture was incubated for 20 mins at 23° C, except
during the time-course experiments, where aliquots of 50 ml were collected over time,
followed by three washes with 10 volumes of Washing Buffer (20 mM Hepes-KOH pH
7.8, 150 mM NaCl, 3 mM MgCl2, 0.5 mM DTT, 15% glycerol, 0.05% NP-40 and 2
mg/ml Heparin). RNA was recovered by adding 200 ml of Recovery Buffer (0.1 M Tris
pH 8.8, 10 mM EDTA, 1% SDS, 0.15 M NaCl, 0.3 M NaOAc and 3 mM MgCl2),
incubating for 10 mins at 65°C, followed by a phenol/chloroform extraction and ethanol
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precipitation. For ATP depletion, 0.2 mM dextrose was added to the reaction prior to
addition to the beads and incubated 10 mins at 37°C. For snRNA depletion experiments,
extracts were pre-incubated with U1-KO oligo (5’ TCTTAAGGTAAGTAT) to a final
concentration of 1 mg/ml or with 0.5 mg/ml U2-KO oligo (5’ CAGATACTACACTTG)
for 10 mins at 37°C, and then added to the reaction.
Reverse transcriptions were performed according to the Superscript III protocol.
After reverse transcription, PAGE was performed as described before (Spingola & Ares,
2000). Primer sequences for reverse transcription are available upon request.
In order to calculate any changes of bound snRNA when Mer1p is present, the
data were normalized to the actin pre-mRNA band, which serves to indicate the relative
amount of recovery from the beads. We took the ratio of each snRNA to actin, and then
divided ratios from samples with Mer1p by ratios from samples lacking Mer1p to obtain
the fold of increased binding by Mer1p.

Commitment Assays. In vitro splicing commitment assays were performed in two
steps or reactions. The first reaction contained 100 fmol of radiolabeled pre-mRNA (from
run-off transcription of Hind III digested plasmid) and 4 ml of splicing extracts
containing or lacking Mer1p in a final volume of 10 ml. ATP was depleted from the
extracts used in the first step by pre-incubation with 0.2 mM dextrose for 15 min at 37°C
prior to addition of pre-mRNA. After incubation at 25°C for 20 mins with the first
extract, 10 ml of new extract were added with 20 mM ATP and a 400-fold molar excess
of unlabeled competitor actin pre-mRNA. Reactions were then incubated for additional
30 min at 16° C and terminated by adding 200 ml of stop buffer (0.3 M NaOAc, 0.2%
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SDS, 1 mM EDTA and 10 mg/ml proteinase K). PAGE analysis and phosphorimaging
were conducted to determine the extent of splicing.

4.6 Acknowledgments
The authors are especially grateful to Dr. Shirley Bissen for support of JA. This work
was supported by the University of Missouri-St. Louis Mission Enhancement program.

4.7 References
Abovich N, Rosbash M. 1997. Cross-intron bridging interactions in the yeast
commitment complex are conserved in mammals. Cell 89:403-412.
Baker BS. 1989. Sex in flies: the splice of life. Nature 340:521-524.
Berglund JA, Chua K, Abovich N, Reed R, Rosbash M. 1997. The splicing factor BBP
interacts specifically with the pre-mRNA branchpoint sequence UACUAAC. Cell
89:781-787.
Black DL. 2003. Mechanisms of alternative pre-messenger RNA splicing. Annu Rev
Biochem 72:291-336.
Brow DA. 2002. Allosteric cascade of spliceosome activation. Annu Rev Genet 36:333360.
Butcher SE, Brow DA. 2005. Towards understanding the catalytic core structure of the
spliceosome. Biochem Soc Trans 33:447-449.
Cheng SC, Abelson J. 1987. Spliceosome assembly in yeast. Genes Dev 1:1014-1027.
Clark TA, Sugnet CW, Ares M, Jr. 2002. Genomewide analysis of mRNA processing in
yeast using splicing-specific microarrays. Science 296:907-910.
Croft L, Schandorff S, Clark F, Burrage K, Arctander P, Mattick JS. 2000. ISIS, the
intron information system, reveals the high frequency of alternative splicing in the
human genome. Nat Genet 24:340-341.
Davis CA, Grate L, Spingola M, Ares M, Jr. 2000. Test of intron predictions reveals
novel splice sites, alternatively spliced mRNAs and new introns in meiotically
regulated genes of yeast. Nucleic Acids Res 28:1700-1706.
Del Gatto-Konczak F, Bourgeois CF, Le Guiner C, Kister L, Gesnel MC, Stevenin J,
Breathnach R. 2000. The RNA-binding protein TIA-1 is a novel mammalian
splicing regulator acting through intron sequences adjacent to a 5' splice site. Mol
Cell Biol 20:6287-6299.
Du H, Rosbash M. 2001. Yeast U1 snRNP-pre-mRNA complex formation without
U1snRNA-pre-mRNA base pairing. Rna 7:133-142.
Dziembowski A, Ventura AP, Rutz B, Caspary F, Faux C, Halgand F, Laprevote O,
Seraphin B. 2004. Proteomic analysis identifies a new complex required for
nuclear pre-mRNA retention and splicing. Embo J 23:4847-4856.

Armisen Garrido, Javier, UMSL, 2007 p.104
Engebrecht JA, Voelkel-Meiman K, Roeder GS. 1991. Meiosis-specific RNA splicing in
yeast. Cell 66:1257-1268.
Forch P, Puig O, Kedersha N, Martinez C, Granneman S, Seraphin B, Anderson P,
Valcarcel J. 2000. The apoptosis-promoting factor TIA-1 is a regulator of
alternative pre-mRNA splicing. Mol Cell 6:1089-1098.
Forch P, Puig O, Martinez C, Seraphin B, Valcarcel J. 2002. The splicing regulator TIA-1
interacts with U1-C to promote U1 snRNP recruitment to 5' splice sites. Embo J
21:6882-6892.
Fu XD. 1993. Specific commitment of different pre-mRNAs to splicing by single SR
proteins. Nature 365:82-85.
Gornemann J, Kotovic KM, Hujer K, Neugebauer KM. 2005. Cotranscriptional
spliceosome assembly occurs in a stepwise fashion and requires the cap binding
complex. Mol Cell 19:53-63.
Gottschalk A, Bartels C, Neubauer G, Luhrmann R, Fabrizio P. 2001. A novel yeast U2
snRNP protein, Snu17p, is required for the first catalytic step of splicing and for
progression of spliceosome assembly. Mol Cell Biol 21:3037-3046.
Gottschalk A, Tang J, Puig O, Salgado J, Neubauer G, Colot HV, Mann M, Seraphin B,
Rosbash M, Luhrmann R, Fabrizio P. 1998. A comprehensive biochemical and
genetic analysis of the yeast U1 snRNP reveals five novel proteins. Rna 4:374393.
Heinrichs V, Ryner LC, Baker BS. 1998. Regulation of sex-specific selection of fruitless
5' splice sites by transformer and transformer-2. Mol Cell Biol 18:450-458.
Jurica MS, Moore MJ. 2003. Pre-mRNA splicing: awash in a sea of proteins. Mol Cell
12:5-14.
Lacadie SA, Rosbash M. 2005. Cotranscriptional spliceosome assembly dynamics and
the role of U1 snRNA:5'ss base pairing in yeast. Mol Cell 19:65-75.
Lallena MJ, Chalmers KJ, Llamazares S, Lamond AI, Valcarcel J. 2002. Splicing
regulation at the second catalytic step by Sex-lethal involves 3' splice site
recognition by SPF45. Cell 109:285-296.
Legrain P, Seraphin B, Rosbash M. 1988. Early commitment of yeast pre-mRNA to the
spliceosome pathway. Mol Cell Biol 8:3755-3760.
Lin RJ, Newman AJ, Cheng SC, Abelson J. 1985. Yeast mRNA splicing in vitro. J Biol
Chem 260:14780-14792.
Lynch KW, Maniatis T. 1996. Assembly of specific SR protein complexes on distinct
regulatory elements of the Drosophila doublesex splicing enhancer. Genes Dev
10:2089-2101.
Nakagawa T, Ogawa H. 1997. Involvement of the MRE2 gene of yeast in formation of
meiosis-specific double-strand breaks and crossover recombination through RNA
splicing. Genes Cells 2:65-79.
Nakagawa T, Ogawa H. 1999. The Saccharomyces cerevisiae MER3 gene, encoding a
novel helicase-like protein, is required for crossover control in meiosis. Embo J
18:5714-5723.
Nandabalan K, Price L, Roeder GS. 1993. Mutations in U1 snRNA bypass the
requirement for a cell type-specific RNA splicing factor. Cell 73:407-415.
Nandabalan K, Roeder GS. 1995. Binding of a cell-type-specific RNA splicing factor to
its target regulatory sequence. Mol Cell Biol 15:1953-1960.

Armisen Garrido, Javier, UMSL, 2007 p.105
Newnham CM, Query CC. 2001. The ATP requirement for U2 snRNP addition is linked
to the pre-mRNA region 5' to the branch site. Rna 7:1298-1309.
Parker R, Siliciano PG, Guthrie C. 1987. Recognition of the TACTAAC box during
mRNA splicing in yeast involves base pairing to the U2-like snRNA. Cell 49:229239.
Perriman R, Ares M, Jr. 2000. ATP can be dispensable for prespliceosome formation in
yeast. Genes Dev 14:97-107.
Perriman R, Barta I, Voeltz GK, Abelson J, Ares M, Jr. 2003. ATP requirement for Prp5p
function is determined by Cus2p and the structure of U2 small nuclear RNA. Proc
Natl Acad Sci U S A 100:13857-13862.
Pikielny CW, Rymond BC, Rosbash M. 1986. Electrophoresis of ribonucleoproteins
reveals an ordered assembly pathway of yeast splicing complexes. Nature
324:341-345.
Puig O, Gottschalk A, Fabrizio P, Seraphin B. 1999. Interaction of the U1 snRNP with
nonconserved intronic sequences affects 5' splice site selection. Genes Dev
13:569-580.
Ruby SW, Goelz SE, Hostomsky Z, Abelson JN. 1990. Affinity chromatography with
biotinylated RNAs. Methods Enzymol 181:97-121.
Rutz B, Seraphin B. 1999. Transient interaction of BBP/ScSF1 and Mud2 with the
splicing machinery affects the kinetics of spliceosome assembly. Rna 5:819-831.
Ryner LC, Goodwin SF, Castrillon DH, Anand A, Villella A, Baker BS, Hall JC, Taylor
BJ, Wasserman SA. 1996. Control of male sexual behavior and sexual orientation
in Drosophila by the fruitless gene. Cell 87:1079-1089.
Scherrer FW, Jr., Spingola M. 2006. A subset of Mer1p-dependent introns requires
Bud13p for splicing activation and nuclear retention. Rna.
Seraphin B, Kretzner L, Rosbash M. 1988. A U1 snRNA:pre-mRNA base pairing
interaction is required early in yeast spliceosome assembly but does not uniquely
define the 5' cleavage site. Embo J 7:2533-2538.
Seraphin B, Rosbash M. 1989. Identification of functional U1 snRNA-pre-mRNA
complexes committed to spliceosome assembly and splicing. Cell 59:349-358.
Siebel CW, Fresco LD, Rio DC. 1992. The mechanism of somatic inhibition of
Drosophila P-element pre-mRNA splicing: multiprotein complexes at an exon
pseudo-5' splice site control U1 snRNP binding. Genes Dev 6:1386-1401.
Siebel CW, Kanaar R, Rio DC. 1994. Regulation of tissue-specific P-element pre-mRNA
splicing requires the RNA-binding protein PSI. Genes Dev 8:1713-1725.
Siomi H, Matunis MJ, Michael WM, Dreyfuss G. 1993. The pre-mRNA binding K
protein contains a novel evolutionarily conserved motif. Nucleic Acids Res
21:1193-1198.
Spingola M, Ares M, Jr. 2000. A yeast intronic splicing enhancer and Nam8p are
required for Mer1p-activated splicing. Mol Cell 6:329-338.
Spingola M, Armisen J, Ares M, Jr. 2004. Mer1p is a modular splicing factor whose
function depends on the conserved U2 snRNP protein Snu17p. Nucleic Acids Res
32:1242-1250.
Spingola M, Grate L, Haussler D, Ares M, Jr. 1999. Genome-wide bioinformatic and
molecular analysis of introns in Saccharomyces cerevisiae. Rna 5:221-234.

Armisen Garrido, Javier, UMSL, 2007 p.106
Staley JP, Guthrie C. 1998. Mechanical devices of the spliceosome: motors, clocks,
springs, and things. Cell 92:315-326.
Stevens SW, Ryan DE, Ge HY, Moore RE, Young MK, Lee TD, Abelson J. 2002.
Composition and functional characterization of the yeast spliceosomal pentasnRNP. Mol Cell 9:31-44.
Tardiff DF, Rosbash M. 2006. Arrested yeast splicing complexes indicate stepwise
snRNP recruitment during in vivo spliceosome assembly. Rna 12:968-979.
Tian M, Maniatis T. 1992. Positive control of pre-mRNA splicing in vitro. Science
256:237-240.
Tian M, Maniatis T. 1993. A splicing enhancer complex controls alternative splicing of
doublesex pre-mRNA. Cell 74:105-114.
Umen JG, Guthrie C. 1995. The second catalytic step of pre-mRNA splicing. Rna 1:869885.
Vilardell J, Warner JR. 1994. Regulation of splicing at an intermediate step in the
formation of the spliceosome. Genes Dev 8:211-220.
Wang Q, He J, Lynn B, Rymond BC. 2005. Interactions of the yeast SF3b splicing factor.
Mol Cell Biol 25:10745-10754.
Wang Q, Rymond BC. 2003. Rds3p is required for stable U2 snRNP recruitment to the
splicing apparatus. Mol Cell Biol 23:7339-7349.
Xu YZ, Newnham CM, Kameoka S, Huang T, Konarska MM, Query CC. 2004. Prp5
bridges U1 and U2 snRNPs and enables stable U2 snRNP association with intron
RNA. Embo J 23:376-385.
Zhang D, Rosbash M. 1999. Identification of eight proteins that cross-link to pre-mRNA
in the yeast commitment complex. Genes Dev 13:581-592.
4.8 Figure Legends
Figure 4.1

Mer1p increases the amount of snRNAs bound to pre-mRNAs that

contain the Mer1p-enhancer element. A) Primer extension analysis of U1, U2, and U6
snRNAs bound to immobilized pre-mRNA (bt-3X-Act) with and without Mer1p. The
amount of Actin pre-mRNA recovered from the beads was quantitated by primer
extension and used to normalize each lane by taking the ratio of snRNA band to actin
band. Dividing the ratio of snRNA/actin with Mer1p by snRNA/actin without Mer1p
provides the fold increase of snRNA binding by Mer1p. Lanes 1-2 are primer extension
on extracts to show that each extract has an equal amount of each snRNA. Lane 5
represents control beads that lack pre-mRNA and shows the background level of snRNAs
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that bind to beads nonspecifically. The data in the tables below each gel include the foldincrease of bound snRNAs by Mer1p for the displayed gel and the averages with standard
deviations of three or more replicate experiments. B) Mer1p’s ability to increase the
binding of snRNAs to pre-mRNA is specific to pre-mRNA that contains the enhancer
element. Primer extension analysis of snRNAs bound to immobilized actin pre-mRNA
lacking the Mer1p-enhancer element.

In B a different actin primer was used that

generates a longer product than in A.

Figure 4.2

Mer1p influences the binding of U1 and U2 snRNA to pre-mRNA

lacking a branchpoint sequence without ATP hydrolysis. A) The RNA affinity assay and
analysis of bound snRNAs was carried out as in Figure 1A, except that a pre-mRNA
lacking a branchpoint sequence was used. Lane 5 is a beads only control, and lanes 1-2
are controls showing equal amounts of each snRNA in the two extracts. The fold
increases in bound snRNAs from this gel and the averages of three or more independent
experiments are reported in the tables below each gel. B) Primer extension analysis of
snRNAs bound to a pre-mRNA lacking a bps when ATP has been depleted by addition of
dextrose.

Figure 4.3

Recruitment of snRNAs by Mer1p is compromised by the deletion

of U1 snRNP protein Nam8p. Splicing extracts from nam8Δ cells either expressing or
not expressing Mer1p were prepared and used in RNA affinity assays. Lane 3 is a beads
only control, and lanes 1-2 are controls showing equal amounts of each snRNA in the two
extracts. Lanes were normalized, and lanes 4 and 5 were compared to calculate the fold
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increase in bound RNA when Mer1p is present. The fold increases in bound snRNAs
from this gel and the averages of three or more independent experiments are reported in
the table below the gel.

Figure 4.4

Disruption of the U1-5’ splice site base pairing interaction does not

disable Mer1p function. Splicing extracts were pre-incubated with an anti-sense oligo
against the 5’end of the U1 snRNA before their addition to immobilized pre-mRNA.
RNA recruitment levels were analyzed by primer extension (lanes 3 and 4). As a control,
the RNA affinity assay was also performed as described in Figure 1A (lanes 5 and 6)
without anti-sense treatment. Lane 7 and 8 are beads only control, and lanes 1-2 are
controls showing equal amounts of each snRNA in the two extracts. U1* represents
cDNA from truncated U1 snRNA. The fold increases in bound snRNAs from this gel and
the averages of three or more independent experiments are reported in the table below the
gel.

Figure 4.5

Time-course analysis of U1 snRNP recruitment to pre-mRNA by

Mer1p. After various incubation periods, bound U1 snRNA was eluted from the premRNA and analyzed by primer extension (left). The data were normalized to the highest
amount of U1 recovered and plotted as the maximum fraction of U1 bound versus time
(right). The averages of two experiments with error bars representing standard error are
shown on the graph.
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Figure 4.6

Mer1p commits pre-mRNA to splicing prior to ATP hydrolysis. In

the first step of the commitment assay ATP was depleted to block the progression of the
assembling spliceosome after U1 binding. In the second step, ATP was added along with
competitor pre-mRNA to chase the reaction to completion. Splicing products were then
analyzed by PAGE.

Lariat formation was measured as the percentage of total

radioactivity in the both the lariat product and lariat-exon two intermediate bands. For
controls, reactions were performed without a second step incubation (lanes 3 and 4) to
indicate that ATP depletion blocks splicing, or without ATP depletion (lanes 5 and 6).
Pre-mRNA, lariat product, and lariat-second exon intermediate are indicated by the
objects to the left of the autoradiograph. The fold increase in lariat formation from this
gel and the averages of three or more independent experiments are reported below the
gel.

Figure 4.7

U2 snRNP plays an active role in the recruitment of U1 snRNP by

Mer1p. The RNA affinity chromatography assay was performed as described before
except that splicing extracts were incubated with an anti-sense oligo (U2-KO) against the
bps interaction sequence of U2 snRNA before their addition to immobilized pre-mRNA.
RNAs bound to immobilized pre-mRNA were analyzed by primer extension (lanes 6-9).
As controls, RNA affinity chromatography was also performed without oligo treatment
(lanes 8-9). In lanes 3-4, U2 anti-sense oligo leads to approximately an 80% reduction in
the amount of full length U2 snRNA in the extracts but has no effect on the amounts of
U1 in the extracts.

U2* represents cDNAs from truncated U2 snRNA.

The fold
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increases in bound snRNAs from this gel and the averages of three or more independent
experiments are reported in the table below the gels.
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CHAPTER V

REGULATION OF THE U2
snRNP ASSEMBLY BY Mer1p

Armisen Garrido, Javier, UMSL, 2007 p.119
5.1 Introduction
The human U2 snRNP was initially purified as a 12S particle containing the U2
snRNA, the seven Sm proteins common to all snRNPs, and two additional specific U2
snRNP proteins called U2-A’ and U2-B’’(Polycarpou-Schwarz, Gunderson et al. 1996),
whose yeast homologues were identified as the Lea1p protein and Yib9 protein (or
Msl1p) respectively. Both proteins were required for the formation of the prespliceosome and presented a high degree of similarity with their humans homologues,
suggesting a conserved function of the U2 snRNPs specific proteins (Caspary and
Seraphin 1998; Tang, Abovich et al. 1996). Posterior’s experiments performed under low
salt conditions revealed that the U2 snRNP was indeed a 17S particle containing all the
12S particle elements and ten additional U2-specific proteins (Will and Luhrmann 2001).
These new U2-specific proteins were classified as components of one big splicing factor,
named Splicing Factor 3 (SF3). Further characterization of the splicing factor SF3
revealed that it was composed of two subunits, SF3a and SF3b, each one containing
several specific proteins (Table 5.1) (Brosi, Hauri et al. 1993).
As occurred with U2-A’ and U2-B”, proteins of the SF3a and SF3b subunits were
also evolutionaraly conserved, and together with the U2 snRNA, were required for the
formation of the pre-spliceosome, and for the formation of the mature 17S particle during
its biogenesis (both subunits bind to the 12S U2 snRNP particle forming the mature 17S)
(Dziembowski, Ventura et al. 2004; Wang, He et al. 2005). Indeed, the depletion of SF3a
and/or SF3b abolished the formation of the 17S U2 particle, blocking the progression of
the splicing reaction. SF3a and SF3b enter in the spliceosome assembly at the same time
as the U2 snRNA and remain associated with the spliceosome until the splicing reaction
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is completed (reviewed in Kramer 1996 and Will and Luhrmann 1997). In vitro, the
formation of the mature U2 snRNP occurs in a stepwise fashion, which is initiated by the
association of the SF3b to the 5’ half of the U2 snRNA from the 12S particle. This
association results in the formation of a 15S particle, which is required for the association
of the SF3a to the 3’ region of the U2 snRNA (where also the Sm proteins, and U2-A’
and U2-B’’ proteins reside) (Kramer, Ferfoglia et al. 2005).
Although the role of SF3 subunits is not totally understood, it has been reported
that multiple regions of SF3a and SF3b are in close proximity with the pre-mRNA,
suggesting that the SF3 complex could be anchoring the U2 snRNP to the pre-mRNA.
Additional support for this function comes from the finding that the p14a protein (a
component of the SF3b subunit) binds to the branchpoint sequence during the
spliceosome assembly (Will and Luhrmann 1997; Gozani, Feld et al. 1996; Gozani,
Potashkin et al. 1998). Interestingly, the proposed yeast homologue of P14p is Snu17p.
SF3a is constituted of three proteins Prp9p, Prp11p, and Prp21p. All of them are
required for the formation of the mature 17S particle, and they influence the structure of
the U2 snRNP in addition to regulating the accessibility of the U2 snRNA to the
branchpoint region (Kramer, Ferfoglia et al. 2005). Prp9p, Prp11p, and Prp21p interact
with one another, and they cross-link to the pre-mRNA, upstream of the branchpoint
sequence during the pre-spliceosome formation (Wang, He et al. 2005). Blocking the
binding of any of these splicing factors to the pre-mRNA prevents the association of U2
snRNP to the pre-mRNA indicating that only fully assembled SF3a associated with the
U2 snRNP are functional in the splicing reaction (Rain, Tartakoff et al. 1996; Wiest,
O'Day et al. 1996). Experimental evidence indicates that during the biogenesis of U2
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snRNP, the SF3a heterotrimer is formed in the cytoplasm and then is targeted to the
nucleus, independent of the U2 snRNP core (U2 snRNA; Sm proteins; U2-A’and U2-B’’)
and SF3b. Once in the nucleus, SF3a is associated with the U2 snRNP in Cajal Bodies
where the U2 snRNA is processed. Finally, in addition to its role during splicing, the
human SF3a subunits contain characteristic structural motifs (most of which are
conserved) that are found in proteins involved in the regulation of transcription and
chromatin remodeling (Kramer, Ferfoglia et al. 2005).
The proteins (Table5.1) and function of the SF3b subunit are also well studied in
the yeast Saccharomyces cerevisiae (reviewed in Wang, He et al. 2005). SF3b subunit is
required for the commitment complex/pre-spliceosome transition as part of the U2
snRNP. Additionally, novel interactions have been described between proteins of the
SF3b subunit (Cus1p) and components of the splicing machinery, such as the NineTeen
Complex (NTC), which is involved in the addition and stabilization of the tri-snRNP to
the pre-mRNA, and proper formation of the active spliceosome (Wang, He et al. 2005).
Moreover, several proteins of the SF3b are required for the proper progression of the
splicing reaction. For example, the deletion of Rcp10 affects the stability of SF3b,
compromising the formation of the pre-spliceosome. Rcp1p is also essential for premRNA splicing as well as Rsd3p. In the case of Rsd3p, which initially was classified as
an auxiliary splicing factor, it has been demonstrated to be associated with other SF3b
proteins, and its deletion causes the paralysis of the splicing reaction after the formation
of commitment complex (Wang and Rymond 2003). Rsd3p is also associated with Yra1p,
which is an RNA export factor, linking the U2 snRNP with RNA trafficking, and
therefore the splicing reaction with other intracellular events.
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Human

S. cerevisiae

Core snRNP proteins
SmB/B
SmD1
SmD2
SmD3
SmE1
SmF1
SmG1
LSM2
LSM3
LSM4
LSM5
LSM6
LSM7
LSM8

Smb1
Smd1
Smd2
Smd3
Sme1
Smf1
Smx2
Lsm2
Lsm3
Lsm4
Lsm5
Lsm6
Lsm7
Lsm8

U2 snRNP specific proteins
U2-A'
U2-B''
SF3a60
SF3a66
SF3a120
SF3b49
SF3b145
SF3b130
SF3b155
SF3b14a-p14
SF3b14b
SF3b10
SF3b125
Table 5.1

Lea1
Msl1
Prp9
Prp11
Prp21
Hsh49
Cus1
Rse1
Hsh155
Snu17
Rds3
?
?

Proteins of the U2 snRNP particle in yeast and in humans (SGD).
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In addition to the U2 snRNP-specific proteins required for the proper progression
of the splicing reaction, the U2 snRNA also plays an important role during the splicing
reaction. For example, it forms base pairs with the branchpoint sequence of the premRNA and it is required in the formation of the active spliceosome. However, before the
mature U2 snRNA can be assembled into the U2 snRNP, it needs to undergo a large
number of post-transcriptional modifications, including addition of a 5’ cap, internal 2’O-methylation and pseudouridylation modifications (Massenet, Motorin et al. 1999). All
these modifications, which are common to all five snRNAs, are often clustered in regions
important for pre-mRNA splicing, indicating their importance in the splicing reaction
(Zhao and Yu 2004; Yu et al., 2005). Interestingly, the U2 snRNA is the most extensively
modified snRNA compared to the other snRNAs. In fact, more than 10% of its total
nucleotides

(approximately

189

nucleotides)

are

either

2'-O-methylated

or

pseudouridylated. In yeast, the process of pseudouridylation modification can be
catalyzed by two different mechanisms (RNA-independent mechanism and RNA-guided
mechanism) (Ma, Yang et al. 2005). Furthermore, the specific location of a given uridine
within the U2 snRNA determines whether it is modified by an RNA-dependent or RNAindependent mechanism, but more important is that the uridines, located in the
branchpoint sequence and its adjacent 3' region, are usually converted to pseudouridines
following transcription. All these modifications are important requirements for the proper
conformation of the U2 particle and for the binding of U2 snRNA to the pre-mRNA.
In previous chapters, we have observed that defects in the integrity of the U2
snRNP were compromising Mer1p activity. For example, in the absence of the nonessential U2 snRNP Snu17p, Mer1p fails to activate the splicing of pre-mRNAs. In
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addition, when the U2 essential protein Prp11p was truncated to abolish its interaction
with the U2 particle, Mer1p could not activate the splicing of Mer1p-dependent introns.
Moreover, previous studies with Bud13p, a protein associated with the Retention and
Splicing complex (RES) that interacts with Snu17p and Prp11p (Dziembowski, Ventura
et al. 2004; Krogan, Cagney et al. 2006;), have shown that it was able to modulate the
splicing activity of Mer1p for some of the Mer1p-dependent introns (Scherrer and
Spingola 2006). Finally, disruption of the U2 snRNA affected the efficiency of Mer1p to
recruit U1 snRNP (Chapter IV), suggesting that the U2 snRNP particle, together with U1
snRNP and the enhancer sequence, was required for Mer1p-funtion.
In this chapter, we focus our study in the effect of U2 snRNP over Mer1p activity
by analyzing the recruitment of the snRNAs in the absence of Snu17p or Bud13p. In
addition, we measure the recruitment of U2 snRNA by Mer1p over time and compare the
relative levels of U1 snRNA over time.
The results show that while snu17Δ affects Mer1p function to enhance the
recruitment of different snRNP to a pre-mRNA containing Mer1p-enhancer element,
bud13Δ partially reduces Mer1p activity. In addition, a time course experiment reveals
that the U2 snRNA is recruited practically at the same time as the U1 snRNA, suggesting
that both U1 and U2 snRNPs could be associated simultaneously to the pre-mRNA when
Mer1p is present. Finally, the requirement of U2 snRNP for Mer1p enhancement activity
is also analyzed by commitment assay using U2 antisense-oligo, leading to the
conclusion that in the absence of the U2 snRNP, Mer1p fails to stabilize the commitment
complex.
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5.2 Materials and Methods
Yeast strains. snu17Δ and bud13Δ gene deletion strains were created from strain
BY4741 (MATα his3-∆1 leu2-∆0 met15-∆0 ura3-∆0) (Invitrogen). Splicing extracts
from the strains were performed as described in Chapter IV.

Commitment Assays. Commitment Assays were performed as described in
Chapter IV, but for U2 snRNA depletion, extracts were pre-incubated with U2-KO oligo
(5’ CAGATACTACACTTG) to a final concentration of 0.5 µg/µl for 10 mins at 37°C,
and then added to the reaction.

In vitro transcription reaction, RNA affinity chromatography assays and primer
extension analyses were done essentially as described in Chapter IV, with the above
modification.
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5.3 Results
Loss of Snu17p abolishes the ability of Mer1p to increase the binding of
snRNAs to pre-mRNA. Snu17p (IST3) is a non-essential, but conserved evolutionary U2
snRNP protein with an RNA recognition motif (RRM) whose proposed mammalian
homolog (P14p) is involved in recognition and binding to the conserved adenosine of the
branchpoint sequence (Gottschalk, Bartels et al. 2001). Gottschalk et al., showed that
during the in vitro splicing reaction Snu17p was able to co-precipitate with pre-mRNA
and with lariat intron-exon 2 intermediate, indicating a direct binding between Snu17p
and the pre-mRNA. Moreover, in yeast the U2 snRNA was specifically coimmunoprecipitated with Snu17p and in humans P14p interacts directly with the SF3b
protein SF3b155 (Will, Schneider et al. 2001). In vitro, the absence of Snu17p stalled the
splicing reaction before the first transesterification reaction, (Gottschalk, Bartels et al.
2001) and also it caused the formation of a spliceosome complex with a migration pattern
different than in a wild type strain. Indeed, the absence of Snu17p caused the
accumulation of a particle containing the pre-mRNA/penta-snRNP complex. When
analyses of this unusual spliceosome complex were performed, they revealed normal
levels for U2, U5 and U6 snRNP. Surprisingly, the levels of U1 and U4 snRNP were
higher than normal, suggesting that deletion of Snu17p affected the splicing reaction
before the release of U1 snRNP and after the binding of the tri-snRNP to the pre-mRNA
(Gottschalk, Bartels et al. 2001). In addition to the formation of this unusual spliceosome
complex, snu17Δ mutants also exhibited a growth defect on a fermentable carbon source
and a unipolar budding phenotype (Ni and Snyder 2001).
Protein analyses using TAP tagged Rcp10p (a component of the SF3b particle)
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revealed that Snu17p was also able to associate with Bud31p, forming a new subunit of
SF3b, denominated p17. The two proteins showed similar levels of recovery at increasing
salt concentrations, indicating a stable association among them. Little is known about the
role of Bud31p and its influences over Snu17p function. Moreover, Bud31p is capable of
interacting with different splicing factors such as Prp19p (part of the NTC complex) or
the U2 protein Prp11p, and its deletion causes splicing defects (Masciadri, Areces et al.
2004). Surprisingly, bud31 diploid mutants exhibit random budding pattern, instead of a
unipolar pattern like snu17 mutants.
In addition to forming a complex with Bud31p, Snu17p also interacts with several
other splicing factors (Table 5.2) including components of the SF3b subunit Rds3p,
Rse1p and Cus1p; components of the commitment complex, Mud2p; components of the
NTC complex Prp19p; and non-splicing factors, including the transcription factor Tbp1p.
Finally, Snu17p has also been associated with two other proteins, Bud13p and Pml1p, in
the RES complex. The RES complex was characterized as a requirement for proper
splicing in vivo as well as nuclear pre-mRNA retention (Dziembowski, Ventura et al.
2004). Since Snu17p was able to interact with two complexes (SF3b and the RES
complex), it was proposed to have a dual function/state. It remains unknown when, with
which regions, or how Snu17p is interacting with its different complexes, and in which
situations Snu17p is part of the U2 snRNP complex or part of other complexes.

Armisen Garrido, Javier, UMSL, 2007 p.128
Snu17p interactions
Protein
Sah1p
Cpr1p
Bud13p
Pgm2p
Ded81p
RRS1
Ssz1p
Car2p
Cef1p
Prp19p
Rds3p
Gts1p
Spt15p

Table 5.2

Function
Hydrolase
Cytoplasmic isomerase
Subunit of the RES complex
Phosphoglucomutase
Cytosolic asparaginyl-tRNA synthetase
Cytoplasmic arginyl-tRNA synthetase
Hsp70 protein
Transaminase (OTAse)
Essential splicing factor
Splicing factor
Splicing factor
Many cellular events; cell cycle and sporulation
Transcription factor

Snu17p interactions. The deletion of Snu17p can affect many

different cellular processes, including splicing, transcription and sporulation (SGD).

In vivo, the deletion of Snu17p caused a reduction in splicing levels of pre-mRNA
including those regulated by Mer1p, suggesting that Snu17p could be required for the
recruitment of the snRNPs to the pre-mRNA. Our hypothesis is that as occurred with
Nam8p, Snu17p is required for the proper recruitment of U1 and U2 snRNP by Mer1p to
the pre-mRNA. Using RNA chromatography, we tested whether Mer1p was able to
increase the binding of U1 and U2 snRNAs to immobilize pre-mRNA in the absence of
Snu17p.

The results from this RNA affinity assay are displayed in Figure 5.1_A.

Without Snu17p, the levels of bound U2 snRNAs are significantly reduced, and there is
no difference in bound snRNA levels with or without Mer1p (lanes 4 & 5). As occurred
in nam8Δ, in the absence of Snu17p, Mer1p cannot stabilize the binding of U2 to premRNA. Surprisingly, the amount of U1 bound to the pre-mRNA is also much lower with
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the snu17Δ extracts (lane 5), indicating that the recruitment of U1 by Mer1p is dependent
on the U2 snRNP protein Snu17p, and supporting the hypothesis that Mer1p must interact
properly with U1, U2 and the intronic enhancer sequence in order to activate the splicing
of Mer1p-dependent introns. Additionally, we looked at the recruitment of U1 and U2 in
snu17Δ splicing extracts at earlier stages during the splicing reaction to measure the true
effect over U1 snRNA (Figure 5.1_B). Since snu17Δ only affects the spliceosome
assembly after the binding of U1 to the pre-mRNA (Gottschalk, Bartels et al. 2001), the
effects observed previously at 20 minutes could be reflecting the pre-spliceosome stage,
in which case U1 was already bound to the pre-mRNA and therefore its levels were
already too high to see any difference with or without Mer1p. We measured the RNA
bound at 5 min, 10 min and 30 min (Figure 5.1_B). In all the time points, in the absence
of Snu17p, Mer1p fails to enhance the recruitment of snRNP at any time during the
splicing reaction, suggesting that in order for Mer1p to stabilize the formation of
commitment complex, the U2 snRNP protein Snu17p is required. We conclude that the
defect caused by snu17Δ is a consequence, at least partially, of the destabilization of the
complex, even in the presence of Mer1p.
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Figure 5.1

Snu17p is required for the recruitment of snRNAs by Mer1p. A)

Splicing extracts from snu17Δ cells either expressing or not expressing Mer1p were
prepared and used in RNA affinity assays. Lane 1 is a beads only control, and lanes 2-3
are controls of RNA affinity assay performed in the presence of Snu17p. Lanes were
normalized, and lanes 4 and 5 were compared to calculate the fold increase in bound
RNA when Mer1p is present. The fold increases in bound snRNAs from the averages of
three independent experiments are reported in the table below the gel. B) Time course
analysis of U1 and U2 snRNP recruitment to pre-mRNA by Mer1p in the absence of
Snu17p. Lane 7 is a beads only control.
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Bud13p modulates Mer1p-splicing activity in a different manner than Snu17p
or Nam8p. Bud13p is a 30.5 KD basic protein required for bud site selection in yeast. Its
deletion results in a unipolar budding phenotype (Ni and Snyder 2001). BUD13 has also
been characterized in many other organisms as a splicing factor (Bud13p mutants cause
splicing defects). Bud13p also interacts with the SF3b subunit Hsh155p, whose human
homologue SF3b155 interacts with P14p (suggested mammalian homologue of Snu17p),
and with several splicing factors (table 5.3) (Ito, Chiba et al. 2001). Additionally, Bud13p
and Snu17p proteins interact in vivo by the yeast two-hybrid assay (Uetz, Giot et al.
2000), and both proteins have been localized throughout the nucleus, and expressed at
different phases during the cell cycle. Curiously, snu17Δ/snu17Δ and bud13Δ/bud13Δ
exhibit the same phenotype of elongated cell shapes. Finally, bud 13 mutants are
synthetically lethal with clf1 mutants. Clf1p plays an important role during the
spliceosome assembly, acting as support between pre-mRNA and spliceosome machinery
(Wang and Rymond 2003). Therefore, Bud13p is not only involved in bud site selection,
but it also participates in other cellular events such as the regulation of the splicing
reaction.
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Bud13p Interactions
Protein
Kip3p
Clu1p
Ist3p
Pml1p
Cef1p
Cwc2p
Prp19p
Prp11p
Cus1p

Function
Kinesin-related motor protein involved in mitotic spindle positioning
eIF3 component
Splicing factor
Subunit of the RES complex
Splicing factor; associated with Prp19p and the spliceosome
Splicing; interacts with Prp19p
Splicing factor
Subunit of the SF3a splicing factor complex
Required for assembly of U2 snRNP into the spliceosome

Table 5.3

Bud13p interactions (SGD).

Bud13p, together with Snu17p and Pml1p, was also identified in a complex
involved in Retention and Splicing of pre-mRNA (RES). Purification of the RES
complex did not show association with snRNA, even though previous results indicated a
specific association between Snu17p and the U2 snRNA. Moreover, Pml1p, which was
previously identified in a complex containing all five snRNPs (Stevens, Ryan et al.
2002), seems to not be involved in the splicing reaction when is forming part of the RES
complex. While commitment complex formation and mobility of spliceosome migration
were affected in a snu17Δ or bud13Δ strain, pml1Δ did not affect the migration of the
spliceosome or commitment complex formation (Dziembowski, Ventura et al. 2004), and
therefore, the hypothesis of dual function/stage of some of the RES proteins could
explain these results. However, it is unclear when or how the RES complex is formed;
although its function remains largely unknown, it has been proposed to be required for
efficient splicing of introns with weak 5' splice sites by preventing the export of premRNA rather than interacting with the splicing machinery. In vitro, the association of
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RES with pre-mRNA is weaker than other splicing factors (Dziembowski, Ventura et al.
2004). Additionally, Bud13p modulates the splicing efficiency of some Mer1p-dependent
introns such as AMA1, which contains a conserved 5’ splice site (Scherrer and Spingola
2006). Nonetheless, since Bud13p is not part of the U2 particle, but still interacts with
some of the U2 snRNP proteins, we hypothesize that in constrast to what was happening
with snu17Δ extract, its deletion will cause only moderate effects, or none, over Mer1p
activity (maybe as a consequence of its interaction with Snu17p and other splicing
factors). Using RNA chromatography assay, the recruitment of U1 and U2 snRNAs to
immobilize pre-mRNA by Mer1p was measured in the absence of Bud13p. Results from
the RNA chromatography assay are displayed in Figure 5.2_A. In the absence of Bud13p,
Mer1p still was able to enhance the recruitment of U1 and U2 snRNAs to the pre-mRNA,
and even though the snRNA levels recruited by Mer1p in a bud13Δ background were
lower than in a wild type strain, they were much higher than the levels observed in a
nam8Δ strain or in a snu17Δ. The result indicated that the activity of Mer1p was not
totally dependent on Bud13p. Since Bud13p has been classified as a splicing factor, and
interacts with many other splicing factors including Snu17p (which is required for Mer1p
activity), its deletion could cause a destabilization of the spliceosomal complex or
malfunction of Snu17p, rather than cause a defect in Mer1p activity.

Armisen Garrido, Javier, UMSL, 2007 p.135

Figure 5.2

Recruitment of U1 and U2 snRNAs in a bud13Δ strain. A) Splicing

extracts from bud13Δ cells either expressing or not expressing Mer1p were prepared and
used in RNA affinity assays. Lane 5 is a beads only control, and lanes 3-4 are controls of
RNA affinity assay performed in the presence of Bud13p. Lanes were normalized, and
lanes 2 and 1 were compared to calculate the fold increase in bound RNA when Mer1p is
present. The fold increases in bound snRNAs from the averages of three independent
experiments are reported in the table below the gel. B) Time course analysis of U1 and
U2 snRNP recruitment to pre-mRNA by Mer1p in the absence of Bud13p.
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Moreover, since it has been reported that, in vivo, for some Mer1p-dependent
introns Bud13p was required for Mer1p activity, maybe bud13Δ effects could be
observed at different stages of the splicing reaction, rather than acting at all stages, as is
the case in snu17Δ or nam8Δ extracts. Time course experiments were performed to
analyze the levels of U1 and U2 in a bud13Δ strain at different times during the formation
of the spliceosome. As it is shown in Figure 5.2_B at early times (10 min) Mer1p slightly
enhances the recruitment of U1, but is only after 20 min. when the differences +/- Mer1p
are significant. This result indicates that Bud13p as a splicing factor could be required for
Mer1p activity at early times of the splicing reaction (during the formation of the
commitment complex or pre-spliceosome), but it does not support the in vivo observation
since Bud13p deletion cannot prevent completely the association of U1 and U2 snRNAs
(as it does the deletion of Nam8p or Snu17p, see Figure 4.3 and Figure 5.1). Since
Bud13p is also a subunit of the RES complex, it was proposed that the RES complex
could play an important role in Mer1p activity regulation, and therefore Mer1p could
have different mode of actions, depending on its interaction with the splicing machinery
or with the RES complex.

Intact U2 snRNP is required for Mer1p activity in vitro. In Chapter IV, we
observed that disruption of U2 snRNA structure by using an anti-sense oligo prevented
almost completely the recruitment of U1 to the pre-mRNA (Figure 4.7). While this result
implies that Mer1p must interact directly or indirectly with U1, U2 and pre-mRNA
simultaneously to activate splicing, this does not prove the necessity of U2 for Mer1p to
fully stabilize the binding of U1 to pre-mRNA. Therefore a commitment assay using a
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primary extract that has U2 inactivated by an anti-sense oligo was performed (Figure5.3).
The results from the commitment assay indicate that intact U2 is necessary for Mer1p to
commit pre-mRNA to splicing. After adding an active secondary extract and competitor
RNA to the commitment reaction, samples with Mer1p show no more splicing than
reactions lacking Mer1p (lanes 1 and 2). Without intact U2 in the first incubation, Mer1p
provides no competitive advantage to splicing in the commitment assay, presumably
because Mer1p must recruit U1 and intact U2 during the first incubation. Without intact
U2, U1 is insufficiently recruited to the pre-mRNA to provide any advantage in this
assay, suggesting that Mer1p commits pre-mRNA to the splicing process by
simultaneously recruiting and/or stabilizing the binding of U1 and U2. When ATP is
depleted, Mer1p can still recruit or stabilize the binding of U1 and U2 during the first
incubation and provide a competitive advantage in assembling into an active spliceosome
when the remaining components are added along with an unlabeled competitor.
However, if U2 is damaged or destroyed, Mer1p cannot sufficiently stabilize the binding
of U1 during the first incubation and provides no advantage to the radiolabeled premRNA when a second fully active extract is added in conjunction with unlabeled
competitor RNA.

In the presence of Mer1p, U2 snRNP is recruited to similar levels as U1 snRNP.
The current model for spliceosome assembly proposes that U2 snRNP is recruited to the
pre-mRNA after the binding of U1 snRNP (Tardiff and Rosbash 2006). In addition, it has
also been proposed that the spliceosome could be pre-assembled before its interaction
with the pre-mRNA (Stevens, Ryan et al. 2002). Therefore, based on the idea that the
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different snRNPs could be interacting prior to their association with the pre-mRNA, and
that U2 snRNP is required for Mer1p function, we propose that Mer1p could be
recruiting jointly U1 and U2 snRNAs to the pre-mRNA. Time course experiments were
performed to measure the recruitment of U2 snRNA in the presence of Mer1p. Then the
U2 snRNA levels were plotted against the levels of U1 snRNA recruited when Mer1p
was expressed (Figure 5.4). Surprisingly, in the presence of Mer1p, the amounts of U1
and U2 bound to the pre-mRNA over different time points are very similar, versus
previous models of snRNA recruitment, where under “normal condition” (no splicing
regulator is required for proper splicing of the intron) U1 snRNA is first recruited and
then U2 snRNA (Figure 5.4_B) (Ruby and Abelson 1988).
In conclusion, our data support a model for the spliceosome assembly where in
the presence of a splicing enhancer regulator, such as Mer1p, U1 and U2 could be
recruited simultaneously to the pre-mRNA. While the current model supports assembly
of the spliceosome is in a stepwise fashion, this has only been tested in a few introns, of
which neither were poorly spliced or required enhancer elements for their splicing.
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Figure 5.3

Requirement of U2 snRNP for Mer1p to activate splicing. The

commitment assay was performed by using the anti-sense U2 oligo to block spliceosome
assembly during the first step incubation. For the second step incubation, extract with
intact U2 and competitor pre-mRNA were added and splicing was measured by PAGE.
Lanes 5-6 are controls indicating that the anti-sense oligo blocks splicing, and lanes 7-8
are controls showing that splicing occurs in the absence of anti-sense oligo. Lanes 1-4
show that Mer1p cannot commit pre-mRNA to splicing if intact U2 is not available
during the first incubation.
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Figure 5.4

Amount of U1 and U2 snRNA recruited at early times in the

presence of Mer1p. The values are expressed as percent of each snRNA bound at 15 min.
Panel B represents previous observations of how the different snRNAs are recruited to
the pre-mRNA (Ruby and Abelson 1988).
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5.4 Discussion
Previous observations concluded that, in vivo, Mer1p required the snRNP specific
proteins Nam8p and Snu17p for the splicing activation of pre-mRNA containing the
Mer1p enhancer element (Spingola and Ares 2000; Spingola, Armisen et al. 2004).
Moreover, in vitro, nam8Δ blocked the ability of Mer1p to enhance the recruitment of
snRNAs to the pre-mRNA. In addition, in vivo, Bud13p was a requirement for the
splicing activation of some Mer1p-dependent introns (Scherrer and Spingola 2006). In
this chapter, we analyzed the in vitro effects of Snu17p and Bud13p over Mer1p function
to enhance the binding of U1 and U2 snRNAs by measuring the levels of RNA recruited
when either protein was deleted. While the deletion of Snu17p caused the same severe
defects in Mer1p activity as nam8Δ extracts, bud13Δ extracts had only a moderate effect
over the recruitment of snRNAs. Indeed, some defect in the snRNAs recruitment in a
bud13Δ strain was only observed at early stages of the reaction, suggesting that it could
be affecting the stabilization of the commitment complex or the transition between
commitment complex and pre-spliceosome. Since the in vitro results for Bud13p deletion
do not reflect the in vivo observations, we propose that the ability of Mer1p to recruit the
snRNPs is linked to its ability to interact properly with them, and since Bud13p is not a
component of any of the snRNPs, its deletion does not affect the recruitment of snRNP
by Mer1p.
Additionally, and in order to support the hypothesis of the U2 requirement for
Mer1p, a commitment assay was performed using extracts that had U2 inactivated by an
anti-sense oligo. The inactivation of the U2 affected the ability of Mer1p to stabilize the
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formation of the commitment complex, indicating that intact U2 snRNP is required for
Mer1p activity.
Finally, and confirming the previous observations that U2 snRNA is required for
recruitment of U1 snRNA, the depletion of the U2 snRNP protein Snu17p also affects the
recruitment of the U1 snRNP, suggesting Mer1p, and maybe other splicing enhancer
regulators modulate the assembly of the spliceosome in a different manner, rather than in
a stepwise fashion. Indeed, when the recruitment of U1 and U2 snRNA is compared at
early stages of the splicing reaction there is no clear difference in the association of the
snRNA to the pre-mRNA, supporting the hypothesis that Mer1p could bring together U1
and U2 snRNPs to the pre-mRNA.
In conclusion, the ability of Mer1p to enhance the recruitment and stabilization of
snRNPs to the pre-mRNA resides in its ability to interact properly and simultaneously
with specific components of the U1 snRNP and U2 snRNP particles.
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CHAPTER VI

SUMMARY and FUTURE
DIRECTION
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In this work we have examined the molecular mechanisms by which Mer1p
activates the splicing of pre-mRNA containing the Mer1p enhancer sequence to better
understand how Mer1p and other enhancer regulators (for which mechanisms of action
remain unknown) regulate the splicing reaction. In vivo, the splicing efficiency of the
meiosis-specific genes AMA1, MER2 and MER3 is significantly increased and detectable
in the presence of Mer1p (Spingola and Ares 2000). In vitro these pre-mRNAs splice
poorly and any attempt to study increases in the splicing efficiency by Mer1p using
traditional in vitro assays have failed (Marc Spingola, personal communication).
Therefore, one of the main goals of this study was to develop an assay that could measure
Mer1p’s effects in vitro and at the same time reflect the in vivo observations. For this
purpose an RNA chromatography assay, modified to study Mer1p function, was
developed. Briefly, a modified biotinylated pre-mRNA was immobilized to streptavidinagarose beads, and incubated with splicing extracts, with or without Mer1p. After
extensive washes, RNAs bound to the pre-mRNA were recovered and analyzed by primer
extension. Using this powerful technique, the in vitro effects of Mer1p on the recruitment
of snRNAs to the pre-mRNA were analyzed and a new model for Mer1p activity was
proposed.
As presented in chapter IV, Mer1p was able to enhance the binding of snRNAs,
and therefore the snRNPs, to pre-mRNA containing the Mer1p-enhancer sequence.
Indeed, the levels observed in the presence of Mer1p were increased about three fold for
U1 snRNA and increased two fold for U2 and U6 snRNAs. Furthermore, in order to
confirm that the in vitro assays reflected the in vivo effects of Mer1p, the same
experiments were conducted, using a pre-mRNA lacking the Mer1p-enhancer sequence
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or using a splicing extract from a nam8Δ strain. As occurred in vivo, the removal of the
enhancer sequence or the absence of Nam8p from the extract prevented Mer1p activity in
vitro, confirming that our in vitro system was mimicking what occurs in vivo.
In addition, previous results suggested that Mer1p could be acting during the early
stages of the spliceosome assembly, influencing the formation of commitment complexes
I and II (Spingola and Ares 2000). In order to focus our studies to the early stages of the
splicing reaction, the branchpoint sequence and its adjacent 3’ region were eliminated
from the pre-mRNA. While the branchpoint sequence is required for the addition of U2
snRNP to the pre-mRNA (Liao, Colot et al. 1992), and its adjacent 3’ region is required
for the ATP activity during the spliceosome assembly (Newnham and Query 2001),
neither region is required for the association of U1 snRNP. Therefore, the deletion of
these regions should prevent the binding of U2 (no pre-spliceosome will be formed) but
U1 should still be able to bind and form the commitment complexes I and II.
Surprisingly, the deletion of these regions not only allowed Mer1p to enhance the
recruitment of U1 (as expected) but also U2 recruitment was enhanced. When the
experiments were performed in the absence of ATP, Mer1p was still able to enhance the
recruitment of U1 and U2 snRNAs, indicating that for the first time, an enhancer
regulator was able to bypass (at least partially) the sequence requirement for the
spliceosome assembly. This set of experiments concluded that Mer1p activated the
splicing by recruiting directly the snRNPs to the pre-mRNA and that the recruitment of
U2 snRNP was ATP independent as well as branchpoint region independent. Previous
work on enhancer elements has been done with the Drosophila Transformer protein and
the mammalian TIA-1 protein and providing evidence that other enhancer factors could
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also recruit directly the snRNPs to the pre-mRNA (Tian and Maniatis 1993; Lynch and
Maniatis 1996; Forch, Puig et al. 2002).
While the fold increase observed for U1 could be a direct effect of the Mer1p
activity, the fold increase observed for U2 and U6 could be an indirect effect due to an
increase in the recruitment of U1. According to the most current model for spliceosome
assembly, U1 is first recruited followed by U2 and then U6 (Tardiff and Rosbash 2006).
Interestingly, while the model proposes an order of assembly of the different snRNPs, it
does not prove that U1 recruits U2 to the pre-mRNA, and U2 recruits the tri-snRNPs. It
only indicates that in order for U2 to be recruited, first U1 needs to be bound to the premRNA. Therefore, in order to analyze any possible direct effect that Mer1p could have
on the recruitment of U2 and U6 snRNAs, different conditions were tested using the
RNA chromatography assay. First, it was attempted to block the binding of U1 by
eliminating the base pairs between the U1 snRNA and the 5’ splice site of the pre-mRNA
(an important interaction for U1 snRNP binding stability) (Cheng and Abelson 1987).
Disruption of this interaction did not prevent the recruitment of the truncated U1 snRNA
nor the increase in the recruitment of U2 snRNA to the pre-mRNA, indicating that the
initial base pairing in the formation of the commitment complex was not a requirement
for Mer1p activity. Moreover, if U2 is recruited after U1, any alteration of U2 should not
affect the recruitment of U1. Subsequently, it was tested whether Mer1p was still able to
enhance the recruitment of U1 when U2 was depleted from the splicing extract.
Surprisingly, and contrary to expectations, when the U2 particle was disrupted, U1
recruitment was severely affected, indicating that the binding of U1 was U2-dependent
and, therefore, in the presence of Mer1p, U1 and U2 did not follow the current stepwise
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assembly model. Indeed, the actual proposed model has only been verified for a few
introns and none of them required any enhancer element for their splicing efficiency.
Additionally, it has been shown that it is possible to purify an active pre-assembled
spliceosome containing all five snRNPs (Stevens, Ryan et al. 2002). Finally,
experimental evidence indicates that the assembly of the spliceosome can be intron
specific, and for some introns this process occurs co-transcriptionally while for other
introns is a post-transcriptional event (Tardiff, Lacadie et al. 2006; Lacadie and Rosbash
2005). Therefore, taking into consideration all of these observations, there is not a clear
and defined mechanism of spliceosome assembly for all pre-mRNAs. The spliceosome is
a very dynamic particle and it is possible that its mode of action/assembly is dependent
on intron characteristics in addition to splicing factors.
The results obtained with the RNA chromatography assay do not distinguish
between a kinetic effect and/or stabilization effect on the snRNPs recruited by Mer1p. To
evaluate any possible kinetic effect that Mer1p could have over the assembly of the
snRNPs, a time course experiment was performed to measure the levels of U1 snRNA
recruited over time. When the levels of U1 snRNA were plotted, with and without
Mer1p, a clear difference in the kinetic association of U1 snRNA recruitment was
observed. Mer1p accelerated the binding of U1 to the pre-mRNA and, therefore,
accelerated the formation of the commitment complex. Although the kinetic experiment
indicates that Mer1p increases the Keq of the commitment complex, it does not address
the possibility that Mer1p could also have a stabilizing effect on the complexes formed,
such as the commitment complex I and II. To address this possibility commitment assays
were performed, where the progression of the splicing reaction was blocked by depleting
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the ATP from the splicing extracts. ATP depletion does not prevent Mer1p activity but it
is an important requirement for the progression of the spliceosome assembly. A proper
pre-spliceosome is not formed in the absence of ATP, blocking the splicing reaction
before the first catalytic step (Cheng and Abelson 1987; Liao, Colot et al. 1992;
Perriman, Barta et al. 2003). The results obtained from the commitment assays indicated
that Mer1p was indeed stabilizing the formation of the commitment complex prior to the
ATP hydrolysis and, therefore, the effect of Mer1p over the snRNPs was a combination
of accelerating the recruitment of the snRNPs to the pre-mRNA and stabilizing the
complexes formed. Using the commitment assay, it was also confirmed that without the
U2 snRNP, Mer1p was no longer able to stabilize these early splicing complexes.
During the progression of this work new splicing factors were identified to be
required for the in vivo Mer1p activity (the U2 snRNP proteins Prp11p and Snu17p and
the RES subunit Bud13p) (Spingola, Armisen et al. 2004; Scherrer and Spingola 2006).
Since Snu17p and Bud13p were non-essential splicing factors, splicing extracts from
snu17Δ and bud13Δ were used in the RNA chromatography assay to test for their ability
to enhance the recruitment of the snRNAs. Surprisingly, only snu17Δ extract reproduced
the same effects observed as with the nam8Δ splicing extract or pre-mRNA lacking
Mer1p-enhancer sequence: a non-enhancement effect. However, the bud13Δ splicing
extract did not produce the same defects as snu17Δ or nam8Δ strains. While snu17Δ
affects all Mer1p-dependent introns in vivo, bud13Δ only affects specific Mer1pdependent introns, so maybe in this particular pre-mRNA the defects were not the ones
expected (maybe due to the pre-mRNA structure), and therefore further experimentation
using a more specific pre-mRNA would be required to determine if deletion of bud13p
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blocks the recruitment of snRNAs. Moreover, there is the possibility that bud13Δ affects
Snu17p function in an intron-specific manner. Finally, the in vivo effects of Bud13p
could be linked to its association with the RES complex and, therefore, the in vitro results
would suggest two different modes of regulation of Mer1p activity, one mediated by the
RES complex and the other mediated by the snRNP factors. Since Snu17p also forms a
complex with another splicing factor, Bud31p, maybe bud31Δ mimics the bud13Δ effect,
in which case it would support the hypothesis of an indirect effect of Bud13p on Mer1p
activity. Thus, additional work is required to address the Bud13p effect on Mer1p
function.
Additionally, there are several splicing factors that remain to be tested for their
ability to interact with Mer1p and/or regulate its activity, and those could bring some new
perspectives on how Mer1p enhances each one of its targets and how Mer1p is regulated.
Interestingly, nam8Δ causes the loss of two splicing factors Snu56p and Snu71p
from the U1 snRNP (Gottschalk, Tang et al. 1998; Zhang and Rosbash 1999) and these
two factors interact via two-hybrid with Mer1p (Spingola, Armisen et al. 2004). Since
Mer1p requires Nam8p and, at the same time, Mer1p interacts with Snu71p and Snu56p,
gel mobility shift assays were used to determine, whether the presence of Mer1p was
sufficient to rescue the loss these factors from the U1 particle in a nam8Δ strain. The
results indicate that without Nam8p, Mer1p could not stabilize the binding of Snu71p and
Snu56p to the U1 snRNP (data not shown). Since Nam8p is required for Mer1p activity
and its loss produces the disassociation of Snu56p and Snu71p from the U1 particle, one
hypothesis is that the loss of interaction between Mer1p with Snu56p and Snu71p in a
nam8Δ background is sufficient to block Mer1p function. In the absence of Snu56p and
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Snu71p, Mer1p could be no longer interact properly with the U1 particle and, therefore, it
would fail to recruit U1 into a proper conformation to the pre-mRNA. It would be
interesting to determine if Snu56p and Snu71p play a role in the activity of the Mer1p
and if both factors are required for Mer1p function.
Finally, the recruitment of U1 and U2 in the presence of Mer1p was measured and
compared to the actual model proposed for the assembly of the snRNPs. If the assembly
of the snRNPs in the presence of Mer1p followed the classic stepwise assembly model,
then the recruitment of U1 snRNA should differ from the recruitment of U2 snRNA,
especially at early stages where the differences are more prominent (between
commitment complex formation and pre-spliceosome) (Ruby and Abelson 1988).
Surprisingly, instead of observing clear differences between U1 and U2 snRNA binding,
both snRNPs appeared to be recruited to the pre-mRNA at the same rate and at the same
time, even at early stages of the splicing reaction, suggesting that in the presence of
Mer1p the recruitment of at least U1 and U2 snRNPs do not follow the stepwise
assembly pathway. Moreover, these results, in combination with the previous finding that
U2 snRNA was required for Mer1p to recruit U1 snRNA, support a different model of
snRNPs recruitment to the pre-mRNA in the presence of the enhancer regulator Mer1p
(Figure 6.1).
While in the absence of Mer1p, U1 is first recruited to form the commitment
complex and then U2 to from the pre-spliceosome, in the presence of Mer1p U1 and U2
snRNPs could be recruited simultaneously (before their binding to the pre-mRNA),
creating an advantageous situation over the stepwise process. This advantageous situation
could result in an increase in the assembly rates and, therefore, an increase in splicing
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efficiency of the Mer1p-dependent introns that otherwise and, due to their specific
characteristics, would be at a disadvantage compared to other efficiently spliced introns.
Since this work is mainly focused on the early stages of the splicing reaction, the
possibility remains that Mer1p could also regulate later stage of the splicing reaction.
Future work is required in order to address whether Mer1p still plays an important role
during the recruitment of the tri-snRNP and/or during the transesterification reactions. In
addition, and based on the limited information about enhancer elements, it would be
interesting to characterize new splicing regulators that may follow a similar mode of
action as Mer1p.
In conclusion, based on the above results that Mer1p must interact with U1
snRNP, U2 snRNP, and the enhancer sequence simultaneously in order to activate the
splicing of its targets, a new model of spliceosome assembly emerges for Mer1pdependent introns. Introns that splice efficiently could recruit the snRNPs in a stepwise
fashion, but when introns require the aid of enhancer factors, such as Mer1p, then a preassembled model promoted by these enhancer elements could provide an advantage over
the classic model, and, as a consequence, an increase in the splicing efficiency of their
targets. The model proposed in this work could also be applied to other splicing enhancer
elements, not only Mer1p, constituting an alternative methods of splicing regulation.
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Figure 6.1

Model for the regulation of spliceosome assembly by Mer1p.

Mer1p could recruit simultaneously U1 and U2, accelerating steps in the spliceosome
formation and at the same time stabilizing any weak complexes formed between the premRNA and the snRNPs, creating an advantage in the formation of active spliceosomes,
increasing the splicing efficiency of its targets.
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